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ABSTRACT 
 
The central nervous system (CNS) is composed of two types of cells:  neurons that send 
electrical signals to transmit information throughout the animal and glial cells.  Glial cells 
were long thought to be merely support cells for the neurons; however, recent work has 
identified many critical roles for these cells during development and in the mature 
animal.  In the CNS, glial cells act as the resident immune cell and they are responsible 
for the clearance of dead or dying material.  After neuronal injury or death, glial cells 
become reactive, exhibiting dramatic changes in morphology and patterns of gene 
expression and ultimately engulfing neuronal debris.  This rapid clearance of 
degenerating neuronal material is thought to be crucial for suppression of inflammation 
and promotion of functional recovery, but molecular pathways mediating these 
engulfment events remain poorly defined.   
Drosophila melanogaster is a genetically tractable model system in which to 
study glial biology.  It has been shown that Drosophila glia rapidly respond to axonal 
injury both morphologically and molecularly and that they ultimately phagocytose the 
degenerating axonal debris.  This glial response to axonal debris requires the engulfment 
receptor Draper and downstream signaling molecules dCed-6, Shark, and Rac1.  
However, much remains unknown about the molecular details of this response.  In this 
thesis I show that Drosophila c-Jun kinase (dJNK) signaling is a critical in vivo mediator 
of glial engulfment activity.  In response to axotomy, glial dJNK signals through a 
cascade involving the upstream MAPKKKs Slipper and TAK1, the MAPKK MKK4, and 
ultimately the Drosophila AP-1 transcriptional complex composed of JRA and Kayak to 
vii 
 
initiate glial phagocytosis of degenerating axons.  Interestingly, loss of dJNK also 
blocked injury-induced up-regulation of Draper levels in glia and glial-specific over-
expression of Draper was sufficient to rescue phenotypes associated with loss of dJNK 
signaling.  I have identified the dJNK pathway as a novel mediator of glial engulfment 
activity and show that a primary role for the glial Slipper/Tak1?MKK4?dJNK?dAP-1 
signaling cascade is activation of draper expression after axon injury. 
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Glia – the “other” brain cell 
The nervous system is made up of two main cell types – neurons and glia.  Neurons are 
electrically excitable cells that are responsible for processing and transmitting 
information in the nervous system.  These cells signal both intra- and intercellularly using 
specialized electrical and chemical mechanisms.  The term “glial cell” comes from the 
Greek word for glue and is used to describe the other non-excitable cells in the nervous 
system.  Glial cells were long thought to be merely space-fillers in the brain and the vast 
majority of neuroscience research was neuron-centric.  However, work over the past few 
decades has begun to reveal the many roles that glial cells play in the brain during health 
and disease.   
 Critical roles have now been discovered for glia in nearly every aspect of brain 
development, maintenance, and function (reviewed in Barres, 2008).  For example, glia 
are required for the survival of neurons during development and in the mature central 
nervous system (CNS) and the peripheral nervous system (PNS) (Riethmacher et al., 
1997; Platel et al., 2010; Tao et al., 2011; Cui et al., 2001; Wilkins et al., 2003; Booth et 
al., 2000).  Glial support of neuronal survival includes the maintenance of neurons 
through release of trophic factors to promote survival (Furuya et al., 2000; Banker, 
1980), delivering metabolites to neurons (Meisingset et al., 2010; Allaman et al., 2011), 
and allowing for gas exchange (Iadecola and Nedergaard, 2007; Haydon and 
Carmignoto, 2006).  Glia also increase synapse formation which promotes the formation 
of neuronal circuits (Ullian et al., 2001; Christopherson et al., 2005) 
 Notably, glial cells also act as the primary immune cell of the nervous system 
3 
 
during neural development and in the mature brain.  Ultimately, about 50% of the 
neurons made during development undergo programmed cell death.  Neuronal cell 
corpses are cleared from the nervous system by glia (Wu et al., 2009; Kurant et al., 
2008; Williams and Rakic, 1988; Freeman et al., 2003).  At the same time other neurons 
undergo axonal, dendritic, or synaptic pruning.  Glial cells help sculpt connectivity in 
the nervous system by engulfing the pruned neurites and synapses, thereby helping to 
ensure that each neuron’s adult targets will be properly innervated (Watts et al., 2004; 
Awasaki and Ito, 2004; Cantera and Technau, 1996; Logan and Freeman, 2007).  In the 
mature brain, glia quickly respond to any pathogens or unwanted material and facilitate 
its elimination (Fierz et al., 1985; Dong and Benveniste, 2001; Vilhardt, 2005; Farina et 
al., 2007). 
 Beyond pruning, the assembly of neural circuits is dramatically affected by the 
actions of glia.  Glial cells regulate axon pathfinding (Chotard and Salecker, 2004), 
fasciculation (Gilmour et al., 2002) and synapse formation (Ullian et al., 2001; Nägler et 
al., 2001; Steinmetz et al., 2006).  In the mature brain, glial cells modulate neuronal 
activity by regulating the timely removal of neurotransmitters from the synaptic cleft, or 
by releasing “gliotransmitters”—glial-derived molecules are thought to directly alter 
synaptic function (Panatier et al., 2006; Ehinger, 1977; Suchak et al., 2003).  By 
interacting with neurons in this way, glial cells are intricately involved in neural circuit 
formation and signaling which underlies complex behaviors including circadian 
rhythms, courtship, and learning and memory (Fellin et al., 2006; Jackson, 2011; Suh 
and Jackson, 2007; Mothet et al., 2006; Gibbs et al., 2008; Augustin et al., 2007; 
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Grosjean et al., 2008).    
 
Subtypes of glia in mammalian nervous system 
Glial cells outnumber neurons in the brains of all species, although the exact glia to 
neuron ratio varies significantly.  There are four major subtypes of glial cells – Schwann 
cells, oligodendrocytes, astrocytes, and microglia.  Each type is well characterized based 
on its location in the nervous system, morphology, and molecular markers.  Myelinating 
and non-myelinating Schwann cells are found in the PNS.  These glial cells are 
important for the development and maintenance of peripheral nerves, for myelination of 
axons and therefore the speed of signal conduction down the axons, and for the 
modulation of synaptic transmission at peripheral synapses such as the neuromuscular 
junction (NMJ) (Bunge, 1993).  Interestingly, Schwann cells are essential for nerve 
regeneration as they secrete growth factors that stimulate axon re-growth after injury 
(Gulati, 1988; Hall, 1986; Ide et al., 1983).   
 Oligodendrocytes are similar to Schwann cells as they also wrap neurons with 
myelin but they are located in the CNS.  Oligodendrocytes have thin processes that wrap 
multiple neurons in the CNS.    
 Astrocytes are the most abundant of the glial cells and, as their name would 
suggest, their cell bodies are star-shaped.  These cells have extensive processes which 
interact with many cells including neurons, other glia and endothelial cells of the brain 
vasculature.  Astrocytes have long been thought to be critical for providing trophic 
support for axons, maintaining levels of neurotransmitters and ions, and contributing to 
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the blood brain barrier (BBB).  Additionally, recent studies have shown that astrocytes 
are present at synapses and are critical for the formation, maturation, and plasticity of 
these structures (Pfrieger, 1997; Ullian et al., 2001; Christopherson et al., 2005; Araque 
et al., 1999; Steinmetz et al., 2006).  This is contrary to the long-held belief that 
synapses consist of only two cells, a pre-synaptic and a post-synaptic neuron.  As a part 
of the “tripartite” synapse, astrocytes express receptors for a number of 
neurotransmitters, allowing them to sense and respond to neuronal activity (Murphy and 
Pearce, 1987).  However, exact roles for astrocytes at the synapse and in coordinating 
neural signaling are still being debated (Nedergaard and Verkhratsky, 2012).     
 Microglia, the final type of glial cells in the CNS, are developmentally unrelated 
to the other glial subtypes as they stem from a hematopoietic lineage.  These cells are 
constantly surveying the brain (Nimmerjahn et al., 2005) and are responsive to a variety 
of traumas - infection, neurodegenerative disease, stroke, or mechanical injury (Graeber 
et al., 1988), for example.  When stimulated, microglia release both pro- and anti-
inflammatory factors, recruit astrocytes and promote the clearance of cellular debris or 
pathogens.  The effects of activated microglia can be both helpful and harmful to the 
CNS and research is ongoing to determine the molecular details of the microglial 
response, its effects, and how it integrates with the response of other glial cells.   
 
The Drosophila melanogaster nervous system as a model for studying adult glia 
While the ultimate goal of most biomedical research is to provide insight to mammalian 
(i.e., human) processes, the innate complexity and redundancy of mammalian systems 
6 
 
often makes the dissection of molecular pathways difficult.  Drosophila melanogaster is 
a genetically tractable system in which to study biological processes in vivo.  The genome 
has been fully sequenced and the ~14,000 genes are well annotated; about 75% of human 
genes are represented in the fly genome (Reiter et al., 2001).  Many genetic tools exist to 
study Drosophila genes, including loss-of-function alleles and over-expression 
constructs.  The GAL4/UAS system allows for tissue specific expression of transgenes, 
allowing for analysis of gene function during specific periods and in specific cell types 
(Brand and Perrimon, 1993).  With this system, genes can be over-expressed, knocked 
down (with UAS-dsRNAi, for example), inactivated (with dominant negative constructs), 
or patterns can be visualized (with UAS-mCD8::GFP or another reporter).   
Recent progress in the identification of glial subtypes and subtype-specific 
reagents make Drosophila particularly useful for the study of glial cell biology (Awasaki 
et al., 2008; Doherty et al., 2009).  Peripheral glia in the PNS of Drosophila represent the 
functional ortholog of mammalian Schwann cells as they ensheath peripheral nerves.  In 
the CNS, three major types of glia have been identified – surface glia, cortex glia, and 
neuropil glia (Figure 1.1).   
 Surface glia surround the outside surface of the brain.  There are two subtypes of 
surface glia – perineurial and subperineurial glia.  The perineurial glia are small, oblong 
cells around the outermost surface of the brain while the sheet-like subperineurial cells 
are inside of the perineurial glia.  Together, the surface glia make up the blood brain 
barrier in the fly.   
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Figure 1.1 
Subtypes of glia in the Drosophila adult CNS 
 
 
8 
 
Figure 1.1 Subtypes of glia in the Drosophila adult CNS.   
 
 
Repo-GAL4 was used to label glial MARCM clones with GFP and the morphology of 
individual glial cells was analyzed in the adult CNS.  Three major subytpes were 
identified:  
 
 (A) Ensheathing glia had a flattened appearance with relatively few branch points and 
their membranes appeared to surround and demarcate distinct compartments of the 
neuropil.  
 
 (B) Cortex glia resided outside the neuropil in the cortex where neuronal cell bodies are 
found and appeared to fully ensheath the soma of every brain neuron within its spatial 
domain.   
 
(C) Astrocytes had a major stalk that projected into the neuropil and branched and 
ramified profusely, ultimately positioning astrocytes membrane processes in close 
proximity to the synapse-rich regions of the glomeruli.   
 
(Adapted from J. Doherty et al., 2009) 
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 Cortex glia, also known as “cell body associated” glia, are found outside of the 
neuropil within the cell cortex of the brain.  The processes of these cells surround the  
neuronal cell bodies in the cortex region and one cortex glial cell can wrap multiple 
neuronal cell bodies (Awasaki et al., 2008). Cortex glia make contact with the blood 
brain barrier and trachea, which are major sites of nutrient and gas exchange in the fly 
brain.  This positioning makes it feasible that these cells may facilitate the transfer of 
nutrients and gases to neurons, similar to the function of the mammalian astrocyte.   
 Finally, the neuropil glia are divided into two subtypes: astrocyte-like glia and 
ensheathing glia.  Astrocyte-like glia have tufted processes that delve deep into the 
neuropil regions where synapses are present.  In the antennal lobe, for example, 
astrocyte-like processes are visible within the synaptic regions of the glomeruli (Doherty 
et al., 2009; Awasaki et al., 2008).  Interestingly, this subtype of cells expresses EAAT-1, 
an excitatory amino acid transporter also present in mammals that permits the cell to 
uptake glutamate from the synapse and therefore to modulate synaptic transmission 
(Doherty et al., 2009; Awasaki et al., 2008; Besson et al., 1999).  In contrast to the 
mammalian astrocyte, Drosophila astrocyte-like glia do not show any obvious changes in 
morphology after neuronal injury and do not appear to be required for the clearance of 
degenerating axonal debris.  The ensheathing subtype of neuropil glial cells are 
morphologically identifiable by their flattened shape and their location along the borders 
of the neuropil (Doherty et al., 2009).  These cells divide the neuropil into subregions, 
perhaps with a functional consequence (Awasaki et al., 2008).  Ensheathing glial 
processes can be visualized surrounding the glomeruli within the antennal lobe but not 
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within these structures (Doherty et al., 2009).    
 
Reactive gliosis in mammals 
Glia are constantly monitoring the nervous system for signs of trauma and quickly react 
to a variety of traumatic events, including excitotoxicity, anoxia, injury, and 
neurodegenerative disease.  Though seemingly different, each of these events triggers a 
common response in astrocytes and microglia that is termed “reactive gliosis”.  In 
general, reactive gliosis involves dramatic alterations in glial morphology and gene 
expression patterns, movement of glial cells or their processes to sites of damage, and 
phagocytosis of dead and degenerating cells (Aldskogius and Kozlova, 1998; Singh et al., 
2011).  Microglia are the primary immune cell of the CNS; their processes are 
continuously moving to survey the brain for changes in the environment (Davalos et al., 
2005).  In response to a trauma, microglia rapidly respond by changing morphology 
(Vilhardt, 2005; Bechmann and Nitsch, 1997), increasing the expression of certain cell 
surface markers, and proliferating (Singh et al., 2011).  These cells quickly migrate to the 
site of damage and begin phagocytosing debris while releasing cytokines and other pro-
inflammatory factors (Halleskog et al., 2011; Huang et al., 2008).  Astrocytes also 
respond with rapid changes to morphology (Bechmann and Nitsch, 1997) and gene 
expression after trauma to the CNS (Murray et al., 1990).  While much work has been 
done to study the molecular details of reactive gliosis and many important factors have 
been identified, questions about this process remain unanswered.   
 Many of the questions currently being addressed by researchers involve reactive 
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gliosis in relation to a specific disease process, both as a result and a potential cause.  
Recent work has identified heterogeneity in the response of glial cells; that is, reactive 
astrogliosis after ischemic injury does not have the same molecular profile as after 
lipopolysaccharide (LPS)-induced neuroinflammation (Zamanian et al., 2012).  
Additionally the reactive process in both microglia and astrocytes is thought to be graded 
with the intensity of the response correlating with the severity of the injury or insult 
(Sofroniew, 2009).   This leads to interesting possibilities:  Are there subpopulations of 
glia within the brain that react differently to various forms of stimulation?  Do the cells 
activate different molecular programs depending on the insult?  Are different signaling 
pathways activated in different cells based on factors such as proximity to the injury site?   
 It is commonly thought that reactive gliosis has both beneficial and harmful 
results.  The phagocytosis of degenerating neuronal debris, cell corpses, or pathogens is 
widely believed to prevent further tissue damage.  For example, it has been shown that 
the clearance of apoptotic neurons after a focal stroke helps to prevent elevated levels of 
chemokines and to limit the severity of the injury (Faustino et al., 2011).  However, 
reactive glia may also cause excessive damage to the surrounding tissue by releasing 
inflammatory cytokines and creating a glial scar which acts as a physical blockade to any 
potential nerve regrowth (Sofroniew, 2009).  In diseases such as multiple sclerosis and 
Alzheimer’s disease, glia appear to be trapped in this reactive state and may in fact hasten 
disease progression (Chang et al., 2012; Canning et al., 1993; Solito and Sastre, 2012; 
Huizinga et al., 2012; Prineas and Parratt, 2012).  Excessively active glia have also been 
implicated in chronic neuropathic pain (Watkins et al., 2001; Tsuda et al., 2005; Zhuang 
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et al., 2005).  To successfully develop targeted therapeutics for neurological disorders 
and brain trauma we need a thorough understanding of underlying molecular events.  
How do neurons and glia communicate following injury?  What pathways drive glial 
function in the injured brain?   
 The signaling mechanisms that underlie both the beneficial and harmful effects of 
reactive gliosis are poorly understood.  This is likely because much of the mammalian 
data regarding reactive gliosis is from in vitro studies which, while useful for identifying 
molecular players, are not ideal for studying the molecular pathways that are present in 
an intact animal because the intricate relationships between cells are not preserved.  
Additionally, the glia in culture may already be “reactive” due to the mechanical 
dissociation required to start a culture or stimulatory factors in the culture media.  By 
utilizing a genetically tractable model organism, Drosophila melanogaster, we are able to 
explore reactive gliosis in vivo.      
 
Studying axon degeneration and glial responses to injury in Drosophila.   
The Drosophila adult olfactory system has been identified and well characterized as a 
tool to understand neuron-glia signaling after brain injury.  Olfactory receptor neuron 
(ORN) cell bodies are housed in the antennae and maxillary palps and send axon 
projections into the antennal lobe of the brain.  All ORNs expressing the same odorant 
receptor (OR) gene synapse on the same distinct glomerulus (Vosshall et al., 1999).  
Conveniently, we can use this fact to genetically label highly reproducible subsets of 
ORN axons.  Promoters for nearly all fly OR genes have been identified and used to 
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generate OR-GAL4 driver lines, which we use to express membrane tethered GFP (UAS-
mCD8-GFP) thereby allowing us to visualize subsets of ORN axons in the intact brain 
(Vosshall et al., 2000).  When antennae or maxillary palps are surgically removed, ORN 
axons are severed.  This induces Wallerian degeneration, a process characterized by 
fragmentation of the axon distal to the injury site (Waller, 1850; MacDonald et al., 2006).  
Within hours of the injury, nearby glial cells begin to show changes in morphology as 
they extend processes to the degenerating axons and begin to initiate the process of 
clearing this debris from the CNS (diagrammed in Figure 1.2B).   
Glial responses to axon injury can be assayed by using repo-GAL4 (a pan-glial 
driver that is not expressed in neurons) to drive expression of marker proteins (e.g. UAS-
mCD8-GFP) or by using an antibody to the engulfment receptor Draper, an excellent 
marker for glial membranes as it is expressed only in glia in the adult brain (MacDonald 
et al., 2006; Doherty et al., 2009).  Removal of the antennae causes a severe trauma to the 
antennal lobe by severing axons innervating 44 of the 50 glomeruli.  Within one day of 
antennal ablation, local glial cells dramatically up-regulate Draper levels and undergo a 
striking expansion of their membranes as judged by membrane tethered GFP 
(MacDonald et al., 2006).  Thus, neurons and glia in the Drosophila brain signal 
intensively to one another after axotomy and the glia respond to this injury 
morphologically and molecularly (Figure 1.2A3, 1.2B). 
Can fly glia specifically recognize severed axons?  Maxillary palps contain only 
~60 ORNs and these innervate six uniquely identifiable antennal lobe glomeruli.  
Severing maxillary palp ORNs results in glia specifically recruiting their membranes and  
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Figure 1.2 
Drosophila adult glia respond to axonal injury 
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Figure 1.2 Drosophila adult glia respond to axonal injury 
 
 
(A) Antibody against Draper, an engulfment receptor, specifically la 
bels glial membranes in the adult CNS.  A1 - Before injury, Draper is visible throughout 
the brain.  A2 – one day after maxillary palp ablation, Draper is visible specifically on the 
injured glomeruli (arrowheads) and along the maxillary nerve (data not shown).  
Neighboring glomeruli that are uninjured do not show this increase in Draper staining.  
A3 – Draper is dramatically increased around the antennal lobe one day after removal of 
the third antennal segment (arrowhead).   
(Adapted from J. Doherty et al., 2009) 
 
(B) Diagram of the adult CNS injury model in Drosophila. ORN cell bodies reside in the 
third antennal segments (purple) or maxillary palps (orange) and send projections to the 
glomeruli within the antennal lobe (AL).  Surgical removal of the antennae or maxillary 
palp severs the neurons and induces a glial response to this injury.  Glial membranes are 
recruited specifically to the injured glomeruli where they phagocytose the debris.   
(Adapted from Logan and Freeman, 2007) 
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Draper to severed axons within hours after injury (Figure 1.2A2, 1.2B) (MacDonald et 
al., 2006).  However, neighboring antennal innervated glomeruli are not covered with 
glial membranes or Draper staining, showing the precision of the glial response.  This 
tells us that glial cells are able to discriminate between injured and uninjured neurons.   
Together, these data tell us that Drosophila axons undergo Wallerian 
degeneration and that glia respond to injured axons with both molecular and 
morphological changes.  The glial response to axon injury can be divided into three 
phases:  activation, engulfment, and termination.  The initial activation step involves the 
glial cell receiving a yet unidentified injury signal, activating engulfment genes and 
mobilizing glial membranes to the severed axons.  The engulfment step, which involves 
the internalization of debris, will be discussed in depth below.  Finally, the termination 
step involves the glial cells returning to their resting state, driven by an increase in the 
Draper-II protein, an alternative splice variant of draper that contains an inhibitory 
domain in its intracellular region (Logan et al., 2012).  The ability of glia to respond to 
axonal injury, combined with the previously discussed advantages of using this genetic 
model system, provides a good rationale for utilizing Drosophila to further characterize 
the molecular details of glial response to neuronal injury and the subsequent engulfment 
of the axonal debris.  
 
Molecular mechanisms of engulfment are conserved from mammals to Drosophila 
Phagocytosis is a highly conserved process that is important during all life stages of a 
eukaryote.  In the developing CNS, phagocytosis occurs as a part of the normal 
17 
 
developmental program as cell corpses are removed and axons are pruned.  In the adult 
CNS, phagocytosis is typically associated with a pathological state such as infection or 
cell death due to trauma.  The invading pathogen or cell debris (material from dying 
cells) must be cleared to restore the health of the organism.  Work from C. elegans has 
helped us to begin to understand how cells engulf apoptotic cell corpses; orthologs for 
components of the C. elegans machinery have been revealed in Drosophila and in 
mammals, suggesting that the molecular underpinnings of phagocytosis are conserved 
between species (Figure 1.3).     
 There are two partially redundant signaling pathways that promote engulfment in 
C. elegans and converge on CED-10/Rac to exert their effects.  The first, made up of 
CED-2, CED-5, and CED-12, acts to promote reorganization of the actin cytoskeleton 
and the engulfment of dead or dying cells (Hedgecock et al., 1983; Ellis et al., 1991).  
The second is composed of CED-1, CED-6 and CED-7 (Ellis et al., 1991; Hedgecock et 
al., 1983).  CED-1 acts as an engulfment receptor that identifies dying cells and initiates 
their degradation after engulfment while CED-6 acts as an adaptor molecule that 
physically binds CED-1 and likely signals through CED-10/Rac1 to promote phagosome 
maturation (Neukomm et al., 2011; Su et al., 2002; Yu et al., 2006; Liu and Hengartner, 
1998; Zhou et al., 2001).   
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Figure 1.3 
Figure 1.3 Current models of engulfment in C. elegans and Drosophila 
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Figure 1.3 Current models of engulfment in C. elegans and Drosophila 
 
Studies of engulfment in C. elegans and Drosophila have unveiled conserved 
mechanisms underlying phagocytosis.   
 
(A) In C. elegans, two partially redundant pathways converge on CED-10 to promote 
reorganization of the cytoskeleton and phagocytosis.  One pathway is composed of the 
engulfment receptor CED-1, the adaptor molecule CED-6, and CED-7.  The parallel 
pathway includes CED-2, CED-5, and CED-12.  
 
 (B) The Drosophila engulfment pathway is composed of Draper, a CED-1 ortholog, and 
adaptor molecules dCed-6 and Shark.  A parallel pathway includes Crk (dCed-2), MBC 
(dCed-5) and dCed-12.  Both of these pathways feed into Rac1, an ortholog of CED-10, 
to promote engulfment via cytoskeletal rearrangements.   
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Recent work has identified orthologous pathways in both Drosophila and 
mammals, indicating that many molecular underpinnings of engulfment have been 
conserved throughout evolution.  The Drosophila CED-1 ortholog draper was originally 
identified for its role in the clearance of embryonic neuronal cell corpses  
(Freeman et al., 2003).  Roles for Draper as an engulfment receptor have now been 
discovered throughout development and in the adult fly.  The Drosophila CED-6 (dCed-
6) has been shown to be required for clearance of degenerating and pruned axon debris 
and to act in the Draper/CED-1 pathway (Doherty et al., 2009; Awasaki et al., 2006).  
Draper signaling has been shown to be required for the developmental pruning of 
dendrites (Williams et al., 2006) and axons (Awasaki et al., 2006; Hoopfer et al., 2006), 
for the removal of presynaptic debris at the larval neuromuscular junction (NMJ) 
(Fuentes-Medel et al., 2009) and for the clearance of adult axons undergoing Wallerian 
degeneration (MacDonald et al., 2006).  In draper null mutants, glia fail to respond in 
any way to antennal or maxillary palp ablation and severed ORN axons linger in the CNS 
for weeks after injury (MacDonald et al., 2006).  Together, these data tells us that the 
dCED-1 receptor Draper and downstream signaling are critical for glia to respond to an 
array of dying cells– apoptotic cell corpses, developmentally degenerating axons, and 
traumatically injured axons.     
The CED-2/5/12 pathway has been recently characterized in Drosophila and was 
shown to be required for the phagocytosis of degenerating axon debris after axotomy 
(Ziegenfuss et al., 2012).  Notably, the Drosophila Crk (dCed-2), MBC (dCED-5), and 
dCed-12 are required in glia to activate phagocytosis and to engulf axonal debris but not 
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for the initial glial response to axonal injury (Ziegenfuss et al., 2012).  Based on this 
pathway’s role in C. elegans where it is required for cell migration, it is surprising that 
glia depleted of Crk/MBC/dCed-12 are able to respond and migrate to injured axons.  
These data indicate that while the basic engulfment pathway components are conserved 
from C. elegans to mammals, there may be some interspecies variability in the exact 
functions and interactions of these pathways.  Alternatively, different engulfment targets 
may invoke slightly different engulfment pathways – degenerating axons may be 
biologically different from cell corpses resulting from programmed cell death.          
Orthologs for components of these known engulfment pathways have also been 
uncovered in mammals.  The closest mammalian sequence orthologs to CED-1/Draper 
(MEGF10 and Jedi-1) have been shown to be expressed in the satellite glial precursor 
cells of the dorsal root ganglion and to be important for glial clearance of cell corpses 
(Wu et al., 2009).  Additionally, when MEGF10 is put into C. elegans under the control 
of the ced-1 promoter, it can partially rescue the engulfment phenotype in ced-1 null 
animals, indicating a conserved molecular function (Hamon et al., 2006).  GULP, the 
mammalian ortholog to CED-6, was also recently shown to be important for phagocytosis 
in an in vitro model as it clusters around the foreign material and its knock down results 
in decreased clearance (Su et al., 2002; Park et al., 2010).  Studies of the mammalian 
orthologs of the CED2/5/12 pathway (CrkII, Dock180 and Elmo) have revealed that this 
complex acts as a guanine nucleotide exchange factor (GEF) that activates Rac1 
(Brugnera et al., 2002; Gumienny et al., 2001). 
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Despite recent progress, many questions remain about the glial response to nerve 
injury.  What activates Draper?  Thus far, only two potential ligands have been identified 
in Drosophila, Pretaporter in the setting of phagocytosis of apoptotic cell corpses 
(Kuraishi et al., 2009) and lipoteichoic acid in the immune response to Staphylococcus 
aureus infection (Hashimoto et al., 2009).  However, these ligands have not been found 
to be involved in the clearance of degenerating axon debris.  Is Draper the only 
engulfment receptor required for clearance of neuronal debris?  What are the downstream 
or parallel effectors that mediate glial engulfment and debris clearance?  To begin to 
address these questions Johnna Doherty, a former graduate student in the Freeman lab, 
conducted a small scale RNAi-based screen for genes specifically in glia cells that, when 
knocked down with RNAi, showed a persistence of degenerating axon material after 
injury in the CNS.  One of the molecules identified in this screen as being required for 
glial engulfment of axon debris is the Drosophila c-Jun NH2-terminal kinase (dJNK); in 
Chapter II I will describe this novel role for dJNK. 
 
An overview of c-Jun NH2 Kinase (JNK) signaling  
Cells are constantly receiving multiple signals from the environment; responsiveness to 
these signals is necessary for the cell, and therefore the animal, to grow, remain healthy, 
and survive.  One pathway that is responsible for receiving a broad range of extracellular 
signals is the Mitogen-activated Protein Kinase (MAPK) pathway (Kyriakis and Avruch, 
2012).   Mitogen-activated protein kinases (MAPKs) are a group of serine/threonine 
protein kinases that are responsive to many extracellular stimuli in organisms ranging 
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from yeast to mammals (Widmann et al., 1999).  Their activation leads to a range of 
responses including transcriptional changes, alterations in metabolic pathways, 
inflammatory responses, proliferation and apoptosis (Kyriakis and Avruch, 2012).  There 
are several subtypes of MAPKs, each of which is responsive to a distinct set of stimuli.  
The Jun NH2-terminal kinase (JNK) is a MAPK that is activated by a variety of 
extracellular signals including growth factors and cytokines as well as by factors that 
stress the cell such as UV radiation (Li et al., 2010; Wang et al., 2012) and ischemia  
(Bogoyevitch et al., 2004; Stronach, 2005; Zeng et al., 2011).  As would be expected of a 
protein that is responsive to such a variety of insults, the downstream effects of JNK are 
varied but include cell survival, growth and metabolic changes, and cell death (Kyriakis 
and Avruch, 2012; Stronach, 2005; Herdegen et al., 1997) 
The specific proteins that act at each stage of activation of the JNK pathway 
depend on the stimulus and the cell type.  Generally, JNK activation is downstream of the 
activation of a receptor and the binding of its adaptor molecules.  The exact adaptor 
molecules involved in the activation of the MAPKKKKs are not fully known but roles for 
small adaptors such as TRAF, SHC, and CRK or GTP binding proteins such as Rac or 
Ras have been suggested (Jaffe and Hall, 2005; Hashimoto, 1999; Min and Pober, 1997a; 
Song et al., 1997a; Dolfi et al., 1998).  Phosphorylation of a MAPKKKK activates this 
enzyme which then phosphorylates and activates a MAPKKK which phosphorylates and 
activates a MAPKK.  These MAPKKs phosphorylate and activate the MAPKs which in 
turn phosphorylate and activate their downstream targets (such as transcription factors).   
The outcomes of the signaling depend on the components involved (Bogoyevitch and 
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Kobe, 2006).  While other downstream targets have been identified, the most common 
result of JNK activation is phosphorylation of c-Jun which, along with c-Fos, makes up 
the activator protein-1 (AP-1) transcription factor (Karin, 1996; Whitmarsh and Davis, 
1996).  This then leads to transcriptional up-regulation of a variety of genes which help 
the cell respond to the triggering stressor.  Alternative targets in mammals include ATF2 
which heterodimerizes with c-Jun to activate expression of c-Jun (Gupta et al., 1995; 
Livingstone et al., 1995) and Elk-1 which is involved in the transcriptional activation of 
c-fos, a component of the AP-1 transcription factor (Yang et al., 1998; Whitmarsh et al., 
1995).  Other, non-transcription factor targets have also been identified such as the 
mitochondrial protein Bcl-xL, an anti-apoptotic protein (Salameh et al., 2010), and 
various microtubule associated proteins (Chang et al., 2003a; Yoshida et al., 2004).  
Interestingly, proteins such as Elk-1 and ATF2 can also be phosphorylated by other 
MAPK cascades, possibly leading to integration of signals received by each of these 
pathways (Baan et al., 2006).  
 JNK signaling and the resulting biological outcomes are complex: a wide variety 
of “stress” signals are able to activate the pathway, multiple proteins are able to act at 
each step of the signal transduction and the combination determines the end signaling 
result(s).  Transcriptional activation downstream of JNK may lead to the upregulation of 
other transcription factors, thereby propagating and amplifying the signaling ongoing in 
the cell.  Alternatively, JNK may be activated for a short, specific period of time (Rallis 
et al., 2010).  All of this signaling may be occurring in a specific subcellular location and 
in the context of other signaling mechanisms (Lowes et al., 2002a; Meng and Xia, 2011).  
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Together, these factors combine such that JNK signaling results in a variety of biological 
outcomes ranging from increased survival to cell death and a number of processes in 
between (Kyriakis and Avruch, 2012).  
 
JNK in Drosophila melanogaster 
In order to study complex signaling pathways such as JNK in vivo, some researchers have 
turned to model organisms.  Drosophila melanogaster is particularly useful as there is 
only one JNK (compared to 3 in mammals).  The amino acid sequence of dJNK, encoded 
by the gene basket, is 65-70% identical to the human JNK1, including critical conserved 
regions: the TPY motif required for activation and key residues in the kinase domain 
(Sluss et al., 1996; Riesgo-Escovar et al., 1996).  In an in vitro model, DJNK was shown 
to phosphorylate both c-Jun and d-Jun indicating that the specificity of the enzyme has 
been conserved throughout evolution (Sluss et al., 1996).  When Hemipterous (HEP, a 
MAPKK homolog) is added to the assay, the phosphorylation of d-Jun is significantly 
increased, indicating HEP is an upstream activator of JNK and that they are both 
involved in a MAPK signal transduction cascade (Sluss et al., 1996).  Together these data 
show that JNK has been evolutionarily conserved from mammals to Drosophila, 
therefore allowing researchers to use this model system to elucidate the details of JNK 
signaling in various biological situations 
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Developmental and immunological roles for dJNK 
One of the key roles identified for dJNK is in dorsal closure during embryonic 
development (Jacinto et al., 2002).  The initiating signal(s) for dorsal closure remains 
unknown but it is thought that small GTPases such as RHO, Rac1 and Cdc42 are 
activated and they activate downstream kinases such as Misshapen and Slipper (Neisch et 
al., 2010; Garlena et al., 2010).  This leads to phosphorylation of HEP, the MAPKK 
upstream of JNK, which then phosphorylates JNK (Glise et al., 1995).  JNK activation 
specifically in the leading edge cells leads to transcriptional activation of dpp (which 
encodes decapentaplegic, a TGF-B related secreted factor) and puc (which encodes 
puckered, a dual-specificity phosphatase), signaling molecules whose presence defines 
the leading edge cells during dorsal closure (Glise and Noselli, 1997; Martin-Blanco et 
al., 1998; Hou et al., 1997).     
Additional proteins have been identified as being involved in dorsal closure but 
their exact placement in the signaling cascade has not been fully elucidated.   SRC42A, a 
tyrosine protein kinase (Tateno et al., 2000) and Shark, a nonreceptor tyrosine kinase 
(Fernandez et al., 2000), have been shown to function upstream of JNK during dorsal 
closure but exactly how they are interacting with other pathway members is unclear.  
Interestingly, Shark and SRC42A have been shown to be critical for Draper dependent 
glial phagocytosis of neuronal debris after axotomy in the adult CNS (Ziegenfuss et al., 
2008), making it possible that a signaling cascade similar to that in dorsal closure is 
activated during the engulfment process.   
 As in mammals, a role for dJNK has been identified in the Drosophila immune 
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response.  In the early work identifying the Drosophila homolog of JNK, it was noted 
that this protein was increased in response to LPS stimulation in S2 cell culture (Sluss et 
al., 1996).  Further studies revealed that dJNK acts downstream of the MAPKKK TAK1 
in a signaling pathway that leads to the upregulation of genes such as cytoskeletal 
proteins (that might help in wound repair, for example) and proapoptotic genes (Boutros 
et al., 2002).  TAK1 may also  feed into the NF-kB pathway that upregulates Relish, a 
protein that when phosphorylated and cleaved can enter the nucleus and induce 
expression of genes including antimicrobial peptides (Silverman et al., 2003; Kim et 
al., 2007).  Interestingly, Relish can inhibit JNK signaling by degrading TAK1, 
providing crosstalk that may help to determine the cell’s fate (Park et al., 2004).  Ongoing 
studies of the role for dJNK in Drosophila immunology may be useful for identifying 
receptors and dJNK interacting molecules involved in glial phagocytosis.  
 
In vitro evidence that JNK may be involved in glial phagocytosis 
Is JNK required for mammalian glia to sense and respond to axon injury?  Data from in 
vitro studies provide compelling evidence that JNK is required for each of the three 
components of reactive gliosis:  proliferation, inflammation, and changes in gene 
expression.  In several culture preparations, JNK has been shown to mediate astrocyte 
proliferation downstream of molecules such as Angiotensin II and Endothelin-1 (Clark et 
al., 2008; Gadea et al., 2008).  A previous study showed that the proliferative effects of 
Angiotensin II in cultured astrocytes were mediated by Src, making it likely that Src is 
upstream of JNK in this pathway (Clark and Gonzalez, 2007).  In primary microglial 
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cultures after application of lipopolysaccharide (LPS, a bacterial component that causes 
an immune reaction), JNK mediates inflammatory changes that include metabolic 
changes and induction of TNF-α, Cox-2, IL-6, and other AP-1 target genes (Waetzig et 
al., 2005).  In an in vivo rat model of neuropathic pain, there is an increase in 
phosphorylated-JNK (P-JNK) after partial sciatic nerve ligation (Ma and Quirion, 2002).  
Together, these studies argue that JNK may play a role in the glial response to nerve 
injury but the details of this involvement and the other signaling molecules involved 
remain unknown.  In Chapter II I will discuss an in vivo role for dJNK in glial 
phagocytosis and will identify other members of the dJNK signaling cascade that are 
required for the clearance of degenerating axonal debris.   
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CHAPTER II 
 
The d-Jun kinase signaling cascade promotes glial engulfment activity through 
activation of draper and phagocytic function. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All work presented in this chapter was conducted in the lab of Marc Freeman, Ph.D..  
Johnna Doherty contributed by identifying dJNK in a candidate-based RNAi screen for 
genes required for glial clearance of degenerating axon debris.  Rachel Hackett 
contributed by performing western blot analyses.  I confirmed the dJNK phenotype and 
carried out all other experiments.   
 
A modified version of this work is currently submitted to Cell Death and Differentiation 
as:  
MacDonald JM, Doherty J, Hackett R, Freeman MR 
The d-Jun kinase signaling cascade promotes glial engulfment activity through activation 
of draper and phagocytic function 
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Abstract 
 
After neuronal injury or death, glial cells become reactive, exhibiting dramatic changes in 
morphology and patterns of gene expression and ultimately engulfing neuronal debris. 
 Rapid clearance of degenerating neuronal material is thought to be crucial for 
suppression of inflammation and promotion of functional recovery, but molecular 
pathways mediating these engulfment events remain poorly defined.  Here we 
demonstrate that Drosophila d-Jun kinase (dJNK) signaling is a critical in vivo mediator 
of glial engulfment activity.  In response to axotomy, we find glial dJNK signals through 
a cascade involving the upstream MAPKKKs Slipper and TAK1, the MAPKK MKK4, 
and ultimately the Drosophila AP-1 transcriptional complex composed of JRA and 
Kayak to initiate glial phagocytosis of degenerating axons.   Interestingly, loss of dJNK 
also blocked injury-induced up-regulation of Draper levels in glia and glial-specific over-
expression of Draper was sufficient to rescue phenotypes associated with loss of dJNK 
signaling.  Thus, the dJNK pathway is a novel mediator of glial engulfment activity and a 
primary role for the glial Slipper/TAK1?MKK4?dJNK?dAP-1 signaling cascade is 
activation of draper expression after axon injury. 
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Introduction 
 
Cell death occurs throughout the life of most metazoans.  The presence of cell corpses 
and cellular debris triggers rapid responses from neighboring professional or non-
professional phagocytes, ultimately promoting corpse engulfment (Gumienny and 
Hengartner, 2001; Giorgi and Deri, 1976; Sears, 2003).  In the central nervous system 
(CNS) glial cells are the primary immune cell type, constantly surveying the neural 
environment for signs of cell death or injury.  Neural injury results in rapid changes in 
glial cellular phenotypes—glia become “reactive” whereby they exhibit dramatic changes 
in morphology and patterns of gene expression and they ultimately phagocytose 
degenerating neuronal debris (Aldskogius and Kozlova, 1998; Sofroniew, 2009; 
Zamanian et al., 2012; Murray et al., 1990).  Reactive glial responses are an early feature 
of most neurodegenerative diseases (Gerber et al., 2012; Perry, V.H., Nicoll, J.A. & 
Holmes, 2010) and occur after any brain injury (Loane and Byrnes, 2010; Nedergaard 
and Dirnagl, 2005), but remarkably little is known about how glial cells sense injury, 
become phagocytic, and eventually engulf neuronal debris. 
 A key mediator of glial responses to neuronal death or injury in Drosophila is the 
engulfment receptor Draper (MacDonald et al., 2006; Freeman et al., 2003) which 
encodes the Drosophila ortholog of the C. elegans cell corpse engulfment receptor CED-
1 (Zhou et al., 2001).  In the Drosophila embryo glial Draper is required for efficient 
clearance of neuronal cell corpses from the developing CNS (Freeman et al., 2003).  In 
the adult brain Draper is essential for activation of glial responses after axotomy and 
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promotion of glial phagocytosis of degenerating axonal debris.  For example, after 
olfactory receptor neuron axotomy glial cells dramatically increase levels of Draper, 
extend membranes to degenerating axons, engulf axonal debris, and then terminate their 
responses and return to a resting state (MacDonald et al., 2006; Logan et al., 2012).  In 
draper mutants, glial cells fail to show any morphological or molecular responses to 
axonal injury and unengulfed axonal debris lingers in the adult brain for the lifespan of 
the fly.   
During glial engulfment of degenerating axons the Draper receptor appears to 
signal in a manner similar to the mammalian Fc, B-, and T-cell immunoreceptors, with 
activation of Draper resulting in downstream engulfment signaling through an Src family 
kinase signaling cascade.  Briefly, SRC42A phosphorylates an intracellular ITAM 
domain on Draper, the non-receptor tyrosine kinase Shark then binds to the Draper 
ITAM, and engulfment is activated (Ziegenfuss et al., 2008).  The phosphotyrosine-
binding (PTB) domain-containing protein dCed-6 also appears to signal downstream of 
the Draper receptor (Liu and Hengartner, 1998), but additional signaling molecules that 
promote engulfment activity in glia remain poorly defined.  Here we show that the 
Drosophila c-Jun amino terminal kinase (dJNK) plays a critical role in glial responses to 
degenerating axonal debris.  Loss of glial dJNK signaling potently blocks axon injury-
induced up-regulation of Draper, activation of a glial phagocytic phenotype, and glial 
clearance of axonal debris.  Our work identifies the dJNK pathway as a novel signaling 
pathway required for glial engulfment signaling and we propose that a primary role for 
dJNK is transcriptional activation of the draper gene after axotomy. 
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Results 
 
Basket signaling is required in adult brain glia for engulfment of axonal debris 
In an RNAi-based screen for novel genes required for glial responses to axonal injury we 
identified basket (bsk), encoding Drosophila c-Jun Kinase (dJNK), as a key regulator of 
glial engulfment of axonal debris.  For glial-specific dJNK knockdown we drove 
expression of UAS-bskRNAi-104569 with the pan-glial driver repo-GAL4 in a background 
where a subset of maxillary olfactory receptor neurons (ORNs) were labeled with 
membrane-tethered GFP (mCD8::GFP).  We then severed ORN axons by maxillary palp 
ablation and assayed clearance of axonal debris 5 days after axotomy.  Whereas control 
animals cleared the vast majority of axonal debris within 5 days after axotomy, we found 
that this glial engulfment activity was potently suppressed by glial bskRNAi (Figure 2.1A-
B).  To confirm this phenotype was specific to bsk, we performed glial specific RNAi 
knockdown using two additional RNAi lines targeting different regions of the bsk 
transcript (bskRNAi-34138 and bskRNAi-TRiP) and found similar results (Supplementary 
Figure 2.1).  bskRNAi suppression of axonal clearance was robust (near 100%) and 
persistent—we observed axonal debris lingering for as many as 30 days after axotomy in 
glial bskRNAi animals, which is longer than the median life-span of adult Drosophila.  
 We next overexpressed puckered (puc), a phosphatase that negatively regulates 
dJNK activity (Martin-Blanco et al., 1998).  Glial-specific expression of PUC 
phenocopied glial bskRNAi, with nearly all axonal debris lingering in the central nervous 
system (CNS) for 30 days after axotomy (Figure 2.1C).  We note that axonal 
fragmentation appears to occur normally and on schedule (i.e. within 1 day) 
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Figure 2.1 
dJNK is required for clearance of axonal debris after nerve injury. 
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Figure 2.1 dJNK is required for clearance of axonal debris after nerve injury. 
 
 
(A) Control animals (OR85e-mCD8::GFP/+; repo-GAL4/+) 0, 5, and 15 days after 
axotomy.  
 
(B) Glial knockdown of dJNK using repo-GAL4 to express UAS-dJNK RNAi 
(OR85e::mCD8::GFP/UAS-dJNK RNAi104569; repo-GAL4/+).  
 
(C) Glial overexpression of UAS-puckered using repo-GAL4 (OR85e::mCD8::GFP/+; 
repo-GAL4/UAS-puckered). 
 
(D) Quantification of GFP intensity in glomeruli for A-C. Error bars depict ± SEM.  
***p<0.001.  
 
(E) Quantification of maxillary nerves with GFP+ debris for A-C.   
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Supplementary Figure 2.1  
Additional RNAi lines targeting dJNK suppress glial clearance of degenerating 
axons. 
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Supplementary Figure 2.1 Additional RNAi lines targeting dJNK suppress glial 
clearance of degenerating axons. 
 
 
 
(A) Control animals (OR85e-mCD8::GFP/+; repo-GAL4/+) 0, 5, and 15 days after 
axotomy.  Two additional non-overlapping UAS-dJNK RNAi lines: (B) UAS-dJNK 
RNAi34138 and (C) UAS-dJNK RNAiHMS00777.  
 
(D) Quantification of GFP+ axon material in experiments shown in A-C.  Error bars 
depict mean ± SEM.  *p<0.05, ***p<0.001.  
 
(E) Quantification of maxillary nerves with GFP+ debris visible in experiments shown in 
A-C.   
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in these backgrounds, indicating glial BSK function is not required for axonal 
degradation.   
 dJNK signaling is known to be important for the development of a number of cell 
types.  We examined glial morphology, numbers, position, and expression of the 
engulfment genes draper and dCed-6 in the CNS of glial bskRNAi and UAS-puc animals 
but found no noticeable defects in glial cell development or engulfment gene regulation 
prior to injury (Supplementary Figure 2.2).  Nevertheless, to exclude the possibility that 
engulfment phenotypes might arise from requirements for bsk in glial development we 
conditionally expressed bskRNAi in adult brain glia using the temperature sensitive 
GAL80ts repressor.  At 18ºC GAL80ts represses activation of the GAL4/UAS binary 
system; however, at 29ºC GAL80ts is inactivated, thereby allowing for activation of 
GAL4/UAS.  We crossed GAL80ts into control and glial bskRNAi backgrounds, raised 
animals at 18ºC, shifted them to 29ºC after eclosion for 7 days, and then performed 
axotomies.  Consistent with a role for dJNK signaling in mature glia after axotomy, we 
found that adult-specific knockdown of bsk was sufficient to block glial engulfment of 
degenerating axons (Figure 2.2A-B).   
 Ensheathing glia are the primary cell type in the Drosophila neuropil that express 
molecular components of the engulfment machinery, including the Draper receptor and 
dCed-6 adaptor molecule, and they phagocytose axonal debris after axotomy (Doherty et 
al., 2009).  To determine whether BSK functions in ensheathing glia we drove expression 
of bskRNAi or UAS-puc with the ensheathing glia-specific driver mz0709-GAL4 and 
assayed glial clearance of degenerating axons.  We found that suppression of dJNK  
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Supplementary Figure 2.2 
Glial development and expression of engulfment genes is normal in glial dJNKRNAi 
animals. 
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Supplementary Figure 2.2 Glial development and expression of engulfment genes is 
normal in glial dJNKRNAi animals. 
 
 
 
(A) Glial morphology (membrane tethered GFP, green), Draper (red) and dCed6 (red) 
immunostains in control and glial dJNKRNAi animals. 
 
(B) Draper protein levels are normal in brains dissected from controls and animals 
expressing glial dJNKRNAi or glial overexpression of PUC.  α-Tubulin was used as a 
loading control. 
 
(C) dCed-6 protein levels are normal in brains dissected from controls and animals 
expressing glial dJNKRNAi or glial overexpression of PUC.  α-Tubulin was used as a 
loading control. 
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Figure 2.2  
The requirement for dJNK in glial engulfment of axonal debris is adult- and 
ensheathing-glia specific.   
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Figure 2.2 The requirement for dJNK in glial engulfment of axonal debris is adult- 
and ensheathing-glia specific.   
 
 
(A)  Control animals (OR85e::mCD8::GFP, tub-GAL80ts /+; repo-GAL4/+) and 
dJNKRNAi animals (OR85e::mCD8::GFP, tub-GAL80ts /UAS-dJNK RNAi104569; repo-
GAL4/+) were raised at 18oC.  After eclosion, adults were shifted to 29oC for at least 7 
days, maxillary palps were ablated and flies were kept at 29oC for 5 days prior to 
assaying axon clearance.   
 
(B)  Quantification for A.  Error bars depict mean ± SEM.  ***p<0.001, ****p<0.0001. 
 
(C)  Control animals (OR85e::mCD8::GFP/+; MZ0709-GAL4/+) or animals with 
ensheathing glia-specific knockdown of dJNK (OR85e::mCD8::GFP/UAS-dJNK 
RNAi104569; mz0709-GAL4/+) were axotomized and assayed for axon clearance 5 days 
after axotomy. 
 
(D)  Quantification for C.  Error bars depict mean ± SEM.  ***p<0.001, ****p<0.0001. 
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signaling in ensheathing glia was sufficient to block glial engulfment function (Figure 
2.2C-D).  Notably, suppressing dJNK signaling in astrocytes, the only other subtype of 
glial cells present in the antennal lobe neuropil, had no effect on glial clearance of axonal 
debris (data not shown). 
 These data identify dJNK signaling as a novel mediator of glial responses to 
axonal injury.  Our data further show dJNK signaling is required in mature ensheathing 
glia—the same glial subtype in which Draper signals to promote phagocytosis of axonal 
debris.  
 
Glial dJNK signaling involves a MAP kinase cascade which signals to the nucleus 
dJNK has been shown to function downstream of a wide range of receptor types and to 
execute signaling events with a diversity of kinases.  Precisely which signaling molecules 
dJNK interacts with appears to be context specific (Stronach, 2005).  To identify 
additional molecules involved in dJNK signaling during glial phagocytic clearance of 
degenerating axons we assayed the roles of known components of JNK signaling 
pathways in Drosophila (Figure 2.3A).  We found that glial-specific knockdown of the 
MAPKKKs Slipper and TAK1, the MAPKK MKK4, and the transcriptional factors Jun-
Related Antigen (JRA, Drosophila c-Jun) and Kayak (KAY, Drosophila c-Fos) 
significantly suppressed glial clearance of degenerating axonal debris 5 days after 
axotomy (Figure 2.3A, Supplementary Figure 2.3).  We confirmed the specificity of 
these RNAi transgenes by using additional RNAi lines that target non-overlapping 
regions of each transcript.   
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Figure 2.3  
Glial c-Jun kinase signaling to the nucleus after axotomy involves SLPR, Tak, 
MKK4, JRA and KAY. 
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Figure 2.3 Glial c-Jun kinase signaling to the nucleus after axotomy involves SLPR, 
Tak, MKK4, JRA and KAY. 
 
 
 (A) UAS-RNAi constructs for the indicated genes were driven in glia using the repo-
GAL4 driver, axons were severed in adults and axonal debris was scored 5 days after 
axotomy as above.  See Supplementary Figure 2.3 for quantifications.   
 
(B) slpr, tak double mutants (slprBS06, tak1/Y; OR85e::mCD8::GFP/+) and (C) y1 w67c23; 
P{EPgy2}kayEY00283 homozygous mutants were assayed for defects in axon clearance. 
slpr and tak1 mutants were also assayed but no clearance defect was noted.  Note—for 
kayak mutants clearance of antennal ORN axons was assayed using 22a-GAL4/UAS-
mCD8-GFP.  
 
(D)  Model of dJNK signaling to the nucleus to induce engulfment gene expression. 
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Supplementary Figure 2.3 
Glial c-Jun kinase signaling to the nucleus after axotomy involves SLPR, Tak, 
MKK4, JRA and KAY. 
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Supplementary Figure 2.3 Glial c-Jun kinase signaling to the nucleus after axotomy 
involves SLPR, Tak, MKK4, JRA and KAY. 
 
Quantification of experiments in Figure 2.3.  Percentage of uninjured glomerular GFP 
intensity is plotted and error bars depict mean ± SEM.  *p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001. 
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We next sought to provide genetic support for a role for this pathway in glial 
engulfment signaling and to explore the effects of complete loss of function of this JNK 
signaling pathway in the clearance of axonal debris.  We therefore performed axotomies 
in slipper, tak1, and kayak mutants and examined their effects on the clearance of GFP-
labeled degenerating axons.  Clearance of axonal debris was largely normal in slipper 
(slipperBS506) and tak1 (tak12) null mutant backgrounds (Figure 2.3B); however, neuronal 
debris persisted at significant levels after axotomy in slipperBS06 , tak12 double mutants 
(Figure 2.3B, Supplementary Figure 2.3).  These data argue that the Slipper and TAK1 
kinases likely function in a redundant fashion in the glial cells responding to axonal 
injury.     
Positive dJNK signaling often leads to changes in gene expression through the 
AP-1 complex.  Drosophila AP-1 (dAP-1) is composed of a heterodimer of JRA and 
Kayak.  The significant phenotypes in Jra and kayak RNAi backgrounds argue for a role 
for dAP-1 in glial responses to axonal injury.  To confirm this we assayed clearance of 
axonal debris in y1 w67c23; P{EPgy2}kayEY00283 homozygous mutant mutants.  We found 
that 7 days after axotomy the vast majority of axonal debris from severed antennal ORN 
axons remained in the CNS (Figure 2.3C, Supplementary Figure 2.3), indicating a 
strong blockade of glial engulfment activity.   
 Together, these data identify a novel role for a dJNK signaling pathway involving 
a Slipper/TAK1?MKK4?BSK?dAP-1 cascade (Figure 2.3D) in promoting glial 
engulfment of degenerating axons after axonal injury.  Since loss of multiple components 
of this pathway (i.e. BSK, TAK1, SLPR, and KAY) block the clearance of a significant 
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amount of axonal debris, positive dJNK signaling appears to be a central regulator of 
glial responses to axonal injury.  Based on the requirements for dAP-1, we propose that 
dJNK signaling acts to regulate glial engulfment behavior through dAP-1-dependent 
transcriptional changes.  
 
JNK signaling is required for axotomy-induced increases in glial Draper levels 
To explore potential roles for dJNK signaling in regulating the expression of glial genes 
we examined expression of the engulfment receptor Draper in bskRNAi and UAS-puc 
backgrounds.  Prior to injury, Draper levels were indistinguishable from control animals 
when we drove bskRNAi or UAS-puc in adult brain glia as judged by immunofluorescence 
(Supplementary Figure 2.2A, Figure 2.4A) and Western blot (Supplementary Figure 
2.2B).  Therefore loss of JNK signaling does not appear to affect baseline levels of 
Draper expression.   
Antennal ablation severs axons ~88% of all ORN axons innervating the antennal 
lobe, resulting in widespread axonal degeneration throughout this brain region and in turn 
a robust increase in Draper levels in glia surrounding the site of injury in wild type 
(Figure 2.4A) (MacDonald et al., 2006; Doherty et al., 2009).  Interestingly, we found a 
complete absence of this axotomy-induced increase in Draper levels when we drove glial-
specific expression of bskRNAi (Figure 2.4A) or UAS-puc (Supplementary Figure 2.4A).  
Thus, loss of JNK signaling suppresses axotomy-induced changes in glial Draper levels 
after antennal ablation.  These data are consistent with the notion that dAP-1 might 
regulate draper expression. 
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Figure 2.4 
dJNK is required for Draper up-regulation after axotomy and activation of 
glial phagocytic function. 
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Figure 2.4 dJNK is required for Draper up-regulation after axotomy and activation 
of glial phagocytic function. 
 
(A)  Immunostains for Draper in control or glial dJNKRNAi animals before or after 
antennal ablation.  Arrows highlight up-regulation of Draper in ensheathing glia (control) 
or lack thereof (dJNKRNAi). 
 
(B)  Draper (red) localization along the maxillary nerve (arrows) before or 1 day after 
maxillary palp ablation.   
 
(C) Draper immunostains (red) in a single antennal lobe before or after axotomy.  A 
subset of maxillary palp ORN axons are shown (green).  Note the lack of Draper staining 
within the glomerulus of glial dJNKRNAi animals compared to controls (arrows).  
 
(D)  Lysotracker Red stains for lysosomal activity one day after maxillary palp ablation.  
Note the punctate accumulation of Lysotracker Red in the OR85e+ glomerulus (green, 
white dotted circle) in controls, but not in glial dJNKRNAi animals.   
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Supplementary Figure 2.4 
dJNK is required for Draper up-regulation after axotomy and activation of 
glial phagocytic function. 
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Supplementary Figure 2.4 dJNK is required for Draper up-regulation after 
axotomy and activation of glial phagocytic function. 
 
(A)  Immunostains for Draper in control or glial UAS-PUC animals before or after 
antennal ablation.  Arrows highlight up-regulation of Draper in ensheathing glia (control) 
or lack thereof (UAS-PUC). 
 
(B)  Draper (red) localization along the maxillary nerve (arrows) before or 1 day after 
maxillary palp ablation.   
 
(C) Draper immunostains (red) in a single antennal lobe before or after axotomy.  Note 
the lack of Draper staining within the glomerulus of glial UAS-PUC animals compared to 
controls (arrows).  
 
 
 
 
 
 
 
 
 
 
 
54 
 
Glia with depleted dJNK signaling recruit Draper to local axonal debris 
The above data raised the possibility that glia lacking dJNK signaling are incapable of 
responding to axonal injury—specifically, glia might be unable to extend membranes to 
degenerating axons and activate a phagocytic phenotype.  To determine whether glial 
cells lacking dJNK signaling were capable of recognizing an injury and recruiting Draper 
specifically to severed axons we assayed axon clearance and Draper localization after 
maxillary palp ablation.  Surgical removal of maxillary palps severs only ~12% of all 
ORN axons, which innervate 6 uniquely identifiable antennal lobe glomeruli.  This 
modest injury does not lead to detectable increases in Draper levels in glia surrounding 
the antennal lobe but one can examine Draper recruitment to (1) degenerating axons 
within identifiable antennal lobe glomeruli or (2) ORNs housed within the maxillary 
nerve as it projects to the antennal lobe (Figure 2.4B-C) (MacDonald et al., 2006).  
Assaying antennal lobe glomerular localization of Draper is especially useful for 
determining whether Draper or other components of the engulfment machinery can be 
recruited to axonal debris, since the engulfing cells must extend membranes into 
glomeruli to reach engulfment targets (see below).  In contrast, ensheathing glia in the 
maxillary nerve are already immediately adjacent to their engulfment targets (i.e. they 
don’t have to migrate), so the maxillary nerve is useful for determining whether glia 
exhibit any changes in Draper localization after axotomy even in backgrounds where glia 
are incapable of migratory behavior (MacDonald et al., 2006).   
One day after maxillary palp ablation in control animals we found a strong 
increase in Draper staining along the maxillary nerve (Figure 2.4B) and Draper levels 
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returned to baseline levels within 7 days after axotomy.  Surprisingly, we found that glial 
expression of either bskRNAi or UAS-puc did not suppress increases in Draper around the 
maxillary nerve: in both bskRNAi and UAS-puc backgrounds Draper accumulated on 
severed maxillary palp ORN axons, though at levels slightly lower than controls (Figure 
2.4B, Supplementary Figure 2.4B).  Thus, glial cells with depleted dJNK signaling are 
capable of detecting axonal injury and responding by recruiting the Draper receptor to 
severed axons.  This is notably different from what is observed when the Draper 
signaling pathway is inactivated—elimination of the non-receptor tyrosine kinase Shark 
or Src family kinase SRC42A from glia completely suppresses Draper recruitment to 
severed axons along the maxillary nerve.  This indicates that dJNK signaling acts 
downstream of initial recruitment of Draper to axonal debris. 
Interestingly, while we observe initial recruitment of Draper to degenerating 
maxillary ORN axons is normal in animals deficient in glial dJNK signaling, glial cells 
appear incapable of terminating their responses to axonal injury.  Even 30 days after 
axotomy Draper levels along the maxillary nerve in glial bskRNAi or UAS-puc backgrounds 
remained elevated (Supplementary Figure 2.5).  We interpret these data to mean that in 
addition to its role in engulfment of axonal debris, dJNK signaling is also critical for 
termination of glial responses to axonal injury. 
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Supplementary Figure 2.5 
Glia fail to terminate their response to axonal injury in animals lacking dJNK 
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Supplementary Figure 2.5 Glia fail to terminate their response to injured axons in 
animals lacking dJNK 
 
 
 Immunostains for Draper in glial UAS-dJNKRNAi and glial UAS-PUC animals 30 days 
after maxillary palp ablation.  Arrows highlight up-regulation of Draper along the 
maxillary nerve.  In control animals, Draper levels return to baseline within 10 days of 
injury.  
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Loss of dJNK signaling suppresses extension of glial membranes to degenerating 
axons and activation of phagocytic function 
 
We next asked whether loss of dJNK signaling blocked the extension of glial membranes 
to degenerating axons.  We therefore assayed glial recruitment of Draper to degenerating 
maxillary ORNs in the antennal lobe, where glia must extend membranes into glomeruli 
to reach their engulfment targets.  In control animals, Draper immunoreactivity was 
detectable one day after maxillary palp ablation throughout the glomeruli housing 
degenerating axonal debris (Figure 2.4C).  In contrast, while we observed an increase in 
Draper immunoreactivity around glomeruli in glial bskRNAi or UAS-puc animals, Draper 
immunoreactivity failed to accumulate in central regions of these structures (Figure 
2.4C, Supplementary Figure 2.4C).  Thus, dJNK signaling is essential for glial 
membrane extension to engulfment targets.  
 Once glia have inserted membranes into glomeruli they activate a phagocytic 
program—glia become Lysotracker positive (a marker for lysosomal activity) and 
internalize axonal fragments (Ziegenfuss et al., 2012).  When we examined Lysotracker 
activity 1 day after maxillary palp ablations we observed strong punctuate Lysotracker 
staining within glomeruli containing degenerating axons in control animals.  However, 
Lysotracker staining was absent from these glomeruli in glial bskRNAi animals (Figure 
2.4D).  Together, these data indicate that dJNK signaling is required for glial membrane 
extension into glomeruli for engulfment of degenerating axonal material and for 
activation of lysosomal activity during glia phagocytic function. 
 
59 
 
Re-expression of draper in glia is sufficient to bypass requirements for dJNK 
signaling  
 
dJNK is known to function upstream of the transcription factor (dAP-1), and we have 
shown that loss of dAP-1 components suppress glial engulfment of degeneration axons.  
In addition, we observed that glia responding to axonal injury in bskRNAi or UAS-puc 
animals failed to up-regulate Draper in response to antennal ORN axotomy.  Together 
these observations raised the intriguing possibility that glial dJNK signaling might 
promote glial responses to axon injury through activation of draper expression.  To 
explore this possibility we drove the expression of Draper-I in control, glial bskRNAi and 
UAS-puc animals and assayed clearance of degenerating axonal debris.  Expression of 
Draper-I in control animals did not affect axon clearance as axonal debris was cleared 
within 5 days (Figure 2.5).  As described above, axonal debris remained 5 days after 
axotomy in glial bskRNAi or UAS-puc animals.  However, when we expressed Draper-I in 
glial bskRNAi or UAS-puc animals we found engulfment defects were completely rescued 
(Figure 2.5).  Thus, increased expression of Draper-I is sufficient to overcome 
engulfment defects in animals with depleted glial dJNK signaling.  These data argue that 
a primary role for dJNK signaling is increasing levels of Draper expression to promote 
axon clearance after axotomy. 
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Figure 2.5 
Over-expression of Draper rescues engulfment defects in dJNK knockdown animals. 
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Figure 2.5 Over-expression of Draper rescues engulfment defects in dJNK 
knockdown animals.   
 
 
(A) Control, glial dJNKRNAi, or glial expressed PUC animals before and 5 days after 
axotomy.   
 
(B) Control, glial dJNKRNAi, or glial expressed PUC animals 5 days after axotomy with 
UAS-Draper-I. 
 
(C)  Quantification from A,B. Data was quantified using a one-way ANOVA and Tukey's 
Multiple Comparison Test.  Error bars depict mean ± SEM.  ***p<0.001. 
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Discussion 
 
This study reveals that axonal injury in the Drosophila brain activates a glial signaling 
pathway composed of Slipper and TAK1, MKK4, dJNK, and the dAP-1 complex which 
ultimately leads to increased levels of Draper in glia and activation of phagocytic 
function.  Interestingly we have recently found that draper gene expression is 
transcriptionally up-regulated after axonal injury (Logan et al., 2012); however, the 
signaling mechanisms that transduce injury signals from Draper to the nucleus have 
remained unclear.  dAP-1 is, to our knowledge, the first transcriptional regulator shown 
to modulate glial phagocytic activation and clearance of degenerating axons, and, based 
on our rescue experiments, it likely does so through regulation of Draper levels. 
 Loss of glial dJNK, or suppression of dJNK signaling by over-expression of the 
phosphatase PUC, resulted in axonal debris lingering in the brain for at least 30 days after 
axotomy (i.e. longer than the mean lifespan of Drosophila).  This is among the strongest 
glial engulfment phenotypes observed in Drosophila, hence dJNK is a critical in vivo 
regulator of glial engulfment activity.  We suspect that activation of dJNK is downstream 
of Draper activation.  Loss of Draper, or its immediate downstream signaling molecules 
SRC42A, Shark, and Rac1 (Ziegenfuss et al., 2008, 2012) also block injury-induced up-
regulation of Draper, and Rac1 (Nagata et al., 1998; Teramoto et al., 1996) and Src 
molecules (Tateno et al., 2000) have been shown to be capable of activating the 
Slipper/TAK complex upstream of JNK.  In addition, we note that loss of JNK signaling 
closely phenocopies draper null mutants.  In draper null animals glia fail to respond 
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morphologically to axonal injury, do not activate phagolysosome maturation, and axons 
are not cleared from the brain (MacDonald et al., 2006; Ziegenfuss et al., 2012).  
However, it remains an open possibility that dJNK signaling is activated by a yet-to-be-
identified additional engulfment receptor that is stimulated by axonal injury.  
In animals with depleted glial dJNK, glia successfully recruit the small amount of 
Draper that is present in these cells prior to injury (referred to as basal Draper) to severed 
axons in the maxillary nerve, indicating that dJNK is not required for glial cells to receive 
the injury signal or for Draper accumulation on degenerating axons.  However dJNK-
deficient glia fail to increase Draper levels in response to injury, to activate phagocytic 
pathways, and to engulf axonal debris.  We interpret these data to mean that dJNK-
dependent increases in levels of Draper after axotomy are critical for axon clearance.  
This notion is supported by multiple lines of evidence.  First, we show a requirement for 
the dAP-1 transcriptional complex in glial engulfment of axonal debris.  Second, we have 
recently demonstrated that draper is transcriptionally up-regulated after axonal injury 
(Logan et al., 2012).  Finally, we show that overexpression of Draper is sufficient to 
rescue JNKRNAi or PUC misexpression phenotypes.  We propose that basal Draper (i.e. 
that before injury) is present in glia in the healthy brain to sense injury; upon activation, 
dJNK signaling promotes dramatic increases in Draper through the cascade described 
above and increased Draper after injury allows efficient clearance of axonal debris.   
 Requirements for c-Jun kinases (JNK) signaling appear to be conserved in 
mammalian reactive gliosis.  JNK signaling (as measured with P-JNK antibodies) appears 
to be activated in response to a broad range of neural injuries including sciatic nerve 
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lesion (Ma and Quirion, 2002), accumulation of glial fibrillary acidic protein (GFAP) in 
models for Alexanders’ disease (Tang et al., 2006), or focal demyelination (Gadea et al., 
2008).  To date, the primary roles for JNK in mammalian glia appear to include 
modulating astrocyte proliferation or pro-inflammatory responses after neural injury.  For 
example, JNK is activated in astrocytes in response to focal demyelination and in primary 
astrocyte cultures JNK appears to act upstream of injury-induced glial proliferation 
(Gadea et al., 2008).  Additionally, LPS treatment of astrocytes in vitro leads to JNK-
dependent increases in CPEB1 phosphorylation and activation of reactive oxygen species 
which promote inflammation (Kim et al., 2011).  Our data argue that a primary role for 
dJNK activation in Drosophila glia after axonal injury is increasing levels of Draper and 
promoting phagocytic activity of engulfing glia.  Such roles have not been assayed for in 
mammalian astrocytes, but post-injury changes in astrocyte expression of a number of 
engulfment factors are well established (Zamanian et al., 2012) and we predict that the 
AP-1 transcription factor is involved in some of these injury-regulated transcriptional 
events.   
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Experimental procedures 
 
Drosophila stocks 
Fly crosses were performed on standard fly media at 25oC with the exception of the 
slprBS06, tak12527/FM7 crosses which were grown on semi-defined medium, a rich 
medium described by Backhaus et al. (Backhaus et al., 1984).   
 
The following Drosophila strains were used:  repo-GAL4 (Leiserson et al., 2000), 
OR85e-mCD8::GFP (gift from B. Dickson, Research Institute of Molecular Pathology, 
Vienna, Austria), mZ0709-GAL4 (Ito et al., 1995), pUAST-mCD8::GFP (Lee and Luo, 
2001), OR22a-GAL4 (Dobritsa et al., 2003), OR85e-GAL4 (kindly provided by J. 
Carlson), slprBS06, tak12527/FM7 (gift from B. Stronach), and pUAST-Draper-I (Logan, 
2012).   
 
The following RNAi stocks were obtained from VDRC:  104569 (bsk), 34138 (bsk),  
34898 (tak), 33516 (slpr), 33518 (slpr), 106449 (slpr), 26928 (MKK4), 26929 (MKK4), 
108561 (MKK4), 10835 (Jra), 107997 (Jra), 6212 (kay). 
 
The following stocks were obtained from the Bloomington Stock Center:  y1 w67c23; 
P{EPgy2}kayEY00283, y-w-;UAS-puckered (pucScer\UAS.cMa), and y[1] sc[*] v[1]; 
P{y[+t7.7] v[+t1.8]=TRiP.HMS00777}attP2.  
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Immunolabeling and confocal microscopy 
Standard methods were used for dissection, fixation, and antibody labeling of the adult 
Drosophila brain (MacDonald and Beach, 2006; Vosshall et al., 2000).  Primary 
antibodies were used at the following concentrations: mouse anti-GFP, 1:250 (Life 
Technologies); rabbit anti-Draper, 1:500 (Freeman et al., 2003); FITC anti-mouse IgG, 
1:200; Cy3 anti-rabbit IgG, 1:200; (Jackson ImmunoResearch) 
Lysotracker staining was performed as described in Ziegenfuss et. al.(Ziegenfuss 
et al., 2012).  Briefly, brains were dissected in PBS, Lysotracker Red was added (1:5000) 
and samples were rocked in the dark at room temperature for 15 minutes.  Brains were 
washed with PBS 5 times quickly then rocked in PBS for 15 minutes at room temperature 
in the dark.  Brains were then fixed with 4% formaldehyde in PBS/Triton for 30 minutes, 
rocking at room temperature in the dark.  The standard antibody staining protocol was 
then performed as described above.  Vectashield was applied to the brains and they were 
stored at 4oC for one hour before imaging on an Intelligent Imaging Innovations Everest 
spinning disk confocal microscope. 
Images were quantified as previously described in MacDonald et. al. (2006).  
Statistics were performed using GraphPad Prism.  In all figures except for Figure 2.1, 
Supplementary Figure 2.1, and Figure 2.5, data was analyzed using a two-tailed Student’s 
t-test.  In Figure 2.1, Supplementary Figure 2.1, and Figure 2.5, a one-way ANOVA and 
Tukey's Multiple Comparison Test was used.    
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Western blot 
Drosophila brains of the indicated genotype were dissected in PBS and homogenized in 
SDS loading buffer (60 mM Tris pH 6.8, 10% glycerol, 2% SDS, 1% -mercaptoethanol, 
0.01% bromophenol blue). For Western analysis, sample containing 
approximately 4 brains were loaded onto 10% SDS-PAGE gels (BioRad), transferred to 
nitrocellulose membranes (BioRad), and probed with rabbit anti-Draper (Freeman et al., 
2003) or  rabbit anti-dCed-6 (Awasaki et al., 2006) antibody at 1:1000 diluted in 
PBS/0.01% Tween-20/5% dry milk. Blots were incubated overnight at 4 degrees, washed 
several times in PBS/0.01% Tween-20 and probed with the appropriate HRP conjugated 
secondary antibody for 2 hours at room temperature. Additional washes were performed 
and the blot was developed using chemiluminescence (Amersham ECL Plus), and 
detected with a Fujifilm Luminescent Imager. The protein blot was stripped with mild 
stripping buffer (0.2M glycine, 0.1% sodium dodecyl sulfate, 1% Tween, pH 2.2) at room 
temperature followed by washes in 1XPBS and 1XPBS + 0.01% Tween-20 and then re-
probed with mouse anti-tubulin (Sigma), 1:1000. 
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CHAPTER III 
Discussion and Conclusions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
69 
 
 Until recently, relatively little was known about glial biology as the majority of 
neuroscience research focused on the neuron.  Our knowledge of the molecular details of 
glial biology has been aided by work done in model organisms such as Drosophila 
melanogaster.  Despite obvious differences between mammals and Drosophila (such as 
the ratio of glial cells to neurons which is much lower in Drosophila, differences in 
specific glial subtypes, and the lack of myelination in Drosophila), it is clear that many 
basic molecular underpinnings of glial cell biology are conserved between vertebrates 
and flies. 
In this dissertation I contribute to the understanding of how glial cells in the CNS 
respond to neuronal injury and phagocytose the resultant debris.  Prior to this work, it 
was known that Draper (dCed-1), an engulfment receptor, is required for glia to receive 
an injury signal from degenerating axons and to engulf degenerating axon debris 
(MacDonald et al., 2006).  Activation of Draper signaling involves SRC42A (a Src 
family kinase, SFK), Shark (a Syk-like non-receptor tyrosine kinase), and dCed-6 in a 
process similar to mammalian immunoreceptor- SRC42A - Shark signaling events 
(Ziegenfuss et al., 2008; Doherty et al., 2009).  Concurrent with my work, it was found 
that Rac1, a small GTPase, is also required for glial cells to become activated 
downstream of Draper activation (Ziegenfuss et al., 2012).  The activation of Rac1 is 
mediated by its phosphorylation by a Guanine Exchange Factor (GEF) composed of 
dCed-2 (Crk), dCed-5 (MBC) and dCed-12 (Ziegenfuss, Doherty, and Freeman 2012).  
Concurrent with my work, it was also found that STAT92E acts downstream of Draper  
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Figure 3.1 
Current proposed model of glial engulfment in Drosophila 
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Figure 3.1 Current proposed model of glial engulfment in Drosophila 
 
Activation of the engulfment receptor Draper initiates the glial reaction to axon injury.  
Draper signaling requires dCed-6, SRC42A and Shark and leads to the activation of 
Rac1.  Rac1 may also be activated by phosphorylation by the Crk/MBC/dCed-12 
complex.  Rac1 activates downstream targets that promote engulfment.  Concurrent with 
my work, it was discovered that STAT92E is required for glial engulfment to occur.  
STAT92 may be activated downstream of Rac1 or possibly SRC42A.  STAT92E 
activation contributes to the transcriptional increase of Draper that occurs in glial cells in 
response to axotomy.  Ultimately, activation of signaling downstream of Draper leads to 
cytoskeletal rearrangements and engulfment of degenerating axonal debris.   
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and Rac1 activation to contribute to the transcriptional increase in Draper that occurs in 
glial cells after axotomy.  Ultimately, activation of Draper leads to the migration of glial 
membranes to degenerating debris, an increase in Draper protein levels, and the eventual 
phagocytosis and clearance of the axonal material.   
Despite the recent advances that have been made in our understanding of the 
molecular processes underlying glial engulfment, many important questions remain.  
How does Draper-SFK-Syk activation translate to changes in the cell that promote 
activation and engulfment?  How does Draper receptor activation lead to an increase in 
Draper protein?  Does Draper signaling reach the nucleus to activate transcription of 
injury responsive genes and therefore promote phagocytosis?  Are there other pathways 
downstream of or in parallel to Draper signaling that lead to activation and engulfment?  
My work, stemming from an RNAi screen for genes required for glial response to axonal 
injury, has provided answers to some of these questions.  Specifically, I have identified a 
novel in vivo role for the c-Jun NH2-terminal kinase (JNK) signaling cascade in the glial 
phagocytic program after axonal injury and have shown that Draper activation leads to 
signaling to the nucleus via the AP-1 transcription factor downstream of dJNK.   
 
dJNK is required for glia to phagocytose neuronal debris in the CNS 
In Chapter II of this thesis I show that the dJNK signaling cascade is required in glial 
cells for phagocytosis of degenerating axonal debris (Figure 3.2, yellow).  Specifically, 
the MAPKKKs Slipper and TAK1, the MAPKK MKK4, the MAPK dJNK and the 
transcription factor dAP-1 are each required for phagocytosis to occur.  When each of  
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Figure 3.2 
dJNK signaling is involved in the glial response to axotomy 
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Figure 3.2 dJNK signaling is involved in the glial response to axotomy 
 
 
 
dJNK signaling is required downstream of Draper signaling for glia to engulf 
degenerating axon debris.  When the components in yellow are knocked down 
specifically in glial cells, glia fail to become phagocytic and to clear degenerating axonal 
debris from the CNS (see text for details).  Arrows with question marks indicate potential 
interactions between molecules that are supported by evidence in the literature.  
Components in blue have been shown preliminarily to be involved in the glial response to 
axotomy.   
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these components is knocked down, axonal debris persists significantly longer than in 
control animals.  Glial cells in close proximity to injured axons in the maxillary nerve 
recruit Draper to the injured nerve, indicating that glia are able to receive and respond to 
an axonal injury signal.  However, when dJNK is knocked down we do not see a dramatic 
increase in Draper protein on the injured glomeruli or around the antennal lobe after 
antennal ablation.  Glial cells do not phagocytose degenerating axonal debris and the 
debris is ultimately not cleared from the CNS.   
To initiate dJNK signaling the MAPKKKs SLPR and TAK1 are activated.  
Interestingly, when I performed experiments with the slpr and Tak1 null alleles 
independently we did not see a clearance defect.  However, when I performed the assay 
with a double null animal, a significant amount of axonal debris remained (Figure 2.3B).  
This indicates redundancy at this level of the signaling pathway, which has also been 
briefly mentioned in a previous study on dorsal closure (Polaski et al., 2006).  To my 
knowledge the redundancy and compensation of the MAPKKKs SLPR and TAK1 have 
not been fully explored, making this an interesting area for future study.  
 Next, I found that the MAPKK MKK4 is required for glial phagocytosis of axonal 
debris.  There are two known Drosophila MAPKKs: MKK4 and MKK7 (also known as 
HEP).  These have been shown to have parallel, non-redundant roles in Drosophila 
development and immune response (Geuking et al., 2009).  However, in vitro studies 
have indicated that MKK4 and MKK7 may act together to activate dJNK; for example, 
both are required for robust JNK phosphorylation in immune cell culture assays (Chen et 
al., 2002; Lawler et al., 1998; Fleming et al., 2000).  Because of this, and because 
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MKK7/HEP was tested only with RNAi knockdown, we cannot definitively rule out HEP 
as a component of the glial dJNK signaling cascade involved in phagocytosis.  However, 
when I expressed a constitutively active HEP construct in the glia of animals which were 
also expressing UAS-DrprRNAi , we did not see clearance.  That is, constitutively active 
HEP is not sufficient to overcome the lack of Draper in glial cells by activating the 
pathway downstream of this receptor.  This, along with the lack of in vivo data supporting 
redundant or complementary roles for MKK4 and HEP, makes this a less likely 
possibility.   
 dJNK is activated by phosphorylation by MKK4.  JNK activation has many 
potential downstream effects including transcriptional activation of genes via the 
transcription factor AP-1 which is a heterodimer of JRA (d-Jun) and KAY (d-Fos).  
When either JRA or KAY is knocked down specifically in glia using RNAi, we see an 
engulfment defect; this is replicated in a kay homozygous mutant animal.  Together, these 
data indicate that dJNK is activated and acts through the AP-1 transcription factor to 
promote engulfment.   
Interestingly, recent work showed that there was an increase in draper gene 
expression after acute nerve injury that correlates with the visible increase in Draper 
protein levels (Logan et al., 2012).  This indicates there must be some signaling to the 
nucleus to induce these changes, but the mechanisms by which this transcriptional 
activation occurred remained unknown.  Since knocking down dJNK signaling led to a 
loss of the increase in Draper protein levels after injury and since this increase in Draper 
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staining is due to a transcriptional activation of draper, it is likely that the dJNK cascade 
is activating Draper transcription via AP-1 binding and activation.   
Together, the data presented in Chapter II show that the dJNK signaling cascade 
is required for glial engulfment of neuronal debris and that this signaling acts via AP-1 to 
activate draper transcription after injury which promotes phagocytosis of axonal debris.   
 
SRC42A, Rac1, and Shark are potential upstream activators of JNK signaling 
downstream of Draper 
 
SRC42A (a Src family kinase, SFK) is known to be required for glial activation and 
phagocytic activity in response to axonal injury; it has been shown to phosphorylate the 
intracellular domain of Draper upon activation of the receptor (Ziegenfuss et al., 2008).  
This phosphorylation allows the association of the Syk-like non-receptor tyrosine kinase 
Shark with the Draper receptor and promotes downstream signaling.  Developmentally, 
SRC42A has been shown to act upstream of JNK activation and the levels of JNK 
activation were correlated with the amount of SRC42A (Tateno et al., 2000).  In vitro, 
Src has also been shown to be required for JNK activation (Nagao et al., 1999; Nagao, 
1998).  These studies provide evidence that JNK may be activated downstream of the 
Draper receptor via SRC42A but they do not suggest a direct mechanism by which this 
may occur.   
Shark has been shown to be required for glial phagocytosis downstream of Draper 
activation (Ziegenfuss et al., 2008).  Interestingly, it has also been shown to increase JNK 
activation and AP-1 activity in two immunological culture systems (Jacinto et al., 1998; 
Takada and Aggarwal, 2004).  Rac was found to act synergistically in this system and 
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stimulation of both Syk and Rac led to potent JNK activation (Jacinto et al., 1998).  
However, like with SRC42A, no direct mechanism of activation has been proposed.   
Rac1 activation has also been shown to be critical for both glial activation and 
phagocytosis (Ziegenfuss et al., 2012).  Rac1 has previously been shown to mediate JNK 
activation as well as to directly impact cell migration via actin rearrangement (among 
other functions) (Raftopoulou and Hall, 2004; Burridge, 2004).  It is likely that Rac is 
acting in both of these functions in glial cells responding to injured axons via Draper 
activation.  Biochemical and genetic experiments indicate Rac1 can activate the dJNK 
cascade through SLPR (Stronach and Perrimon, 2002; Su et al., 1998).  To activate 
SLPR, Rac binds to the CRIB domain which releases the protein’s auto-inhibition.  MSN 
also interacts with SLPR by binding to the LZ-CRIB domain which also releases the 
auto-inhibition (Garlena et al., 2010).  While both Rac and MSN can activate SLPR 
alone, there is a significant increase in the downstream JNK activity when both Rac and 
MSN are activated (Garlena et al., 2010).  It has been proposed that Rac is the primary 
activator and that its binding and the subsequent release of SLPR’s auto-inhibition 
exposes the binding site for MSN (Garlena et al., 2010).  It is feasible that this 
mechanism of SLPR activation is taking place in glial cells downstream of Draper 
activation.  Although we did not discover a clearance phenotype when knocking down 
MSN in glial cells, there are many caveats to the experiment.  Namely, the RNAi 
constructs used may not be effectively knocking down the protein.  Since Rac1 may be 
the primary activator of SLPR activation, the knockdown achieved with the MSN RNAi 
construct may not have been sufficient to decrease activation of SLPR and transduction 
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of the signal along the dJNK pathway.  Alternatively, MSN may enhance signaling 
initiated via Rac1 through SLPR but it may not be necessary for it to occur, so a 
phenotype may not be seen if Rac1 signaling is intact.  An alternative method for 
determining a role for MSN in activating SLPR in glia would be to perform the clearance 
assay with a trans-heterozygous rac1 and msn mutant animal to see if there is any 
additive phenotype observed.  However, because small amounts of either protein may be 
sufficient to induce SLPR activation and therefore signal transduction through the dJNK 
cascade, we may not be able to see a failure to clear axons even when both Rac and MSN 
are knocked down. 
 
Regulation of draper transcription in glial cells after axonal injury 
Recent work by Johnna Doherty, another graduate student in the Freeman Lab, has 
explored the regulation of both basal and injury-induced draper expression (Doherty et 
al., submitted).  In order to study the transcriptional regulation of draper, a series of 9 
potential draper enhancer elements (termed dee2-dee10) were created (Doherty et al.,  
submitted).  The fragments, primarily intronic sequences from the region beginning 
~40kB upstream of the draper locus, were cloned into the GAL4-based pBGW vector 
(Karimiet al., 2002) and inserted into identical genomic locations (Figure 3.3A).  Each 
construct was used to drive the expression of UAS-mCD8::GFP and its expression before 
and after injury was assayed.  No glial expression was visible either before or after injury 
with dee2-, 3-,4-,5-, or 6-GAL4 or dee8-,9- or 10-GAL4.  dee7-GAL4, composed of a  
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(Adapted from  J. E. Doherty et al., submitted) 
 
 
 
 
 
 
 
 
 
Figure 3.3 
The draper locus contains an injury responsive element 
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Figure 3.3 The draper locus contains an injury responsive element  
 
(A) Schematic representation of the draper locus and regions used to generate Draper 
Enhancer Elements 2-10 (DEEs). Blue box highlights DEE7 region located in the first 
intron of the draper gene. Red lines indicate Stat92E binding sites and green lines 
indicate AP-1 binding sites in DEE7  
 
(B) Single slice confocal images of antennal lobe regions.  dee7-GAL4 driving two copies 
of UAS-mCD8::GFP; no injury, one day after antennal ablation (-antenna), one day after 
maxillary palp injury (-maxillary palp). Dashed circles outline antennal lobes, axonal 
terminations of injured neurons. Arrows show areas in ventral region of antennal lobe 
responding to maxillary palp injury.  
(adapted from  J. E. Doherty et al., submitted) 
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sequence located within the first intron of the draper locus, showed low-level expression 
before injury in randomly distributed astrocyte-like glia throughout the neuropil but not 
in the cortex or ensheathing glia.  This element showed a dramatic increase in GFP 
expression one day after antennal ablation and a smaller, more specific, increase one day 
after maxillary palp ablation (Doherty et al., submitted) (Figure 3.3B).  This reporter tells 
us that the sequence in the dee7 fragment is responsive to injury and that this 
responsiveness is graded – more severe injury results in a more robust response.  This 
tool provides us with a way to study the effects of upstream signaling on draper 
transcriptional activation.   
The AP-1 transcription factor is known to bind preferentially to the sequence 
TGACTCA in order to activate gene transcription.  To determine if draper is activated by 
the binding of the AP-1 transcription factor to an enhancer segment known to respond 
after injury, we searched the dee7 sequence for an AP-1 consensus binding site.  Within 
the 2619 base pair region, I identified two AP-1 consensus binding sites (TGACTCA) 
(Figure 3.3A).  In order to determine whether AP-1 binding is critical for the activation 
of dee7-GAL4 and therefore for the activation of draper after injury, I mutated the AP-1 
binding sites to prevent the transcription factor from binding.   These experiments are 
ongoing but I expect that when both AP-1 sites are mutated we will see a significant 
decrease in dee7-GAL4 driven GFP expression after injury when compared with control 
animals.  This result would provide direct evidence that AP-1 is required for the 
transcriptional increase in draper that occurs in glial cells in response to neuronal injury 
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and it would identify the exact region within the draper enhancer that is activated by AP-
1.     
 
Transcriptional activation of draper as a point of integration for signaling cascades 
In order to respond appropriately to the many extracellular signals being recognized by a 
cell, crosstalk between signaling pathways has been shown to occur.  This integration of 
signals can occur at multiple levels – the receptor (Lowes et al., 2002b), various points 
along the signaling pathway (Jacinto et al., 1998), or at the promoter of a responsive gene 
(Chen et al., 1999).  This integration of signaling cascades can either enhance or inhibit 
the cell’s response (Kim et al., 2005; Su et al., 1994).   
In the case of glial cells responding after neuronal injury, such integration may be 
required to determine the severity of the injury and the intensity of the response required.  
Experiments by Johnna Doherty using the dee7-GAL4 element show that there is a 
graded response to neuronal injury in Drosophila.  When antennae are ablated, therefore 
injuring the majority of ORNs projecting into the CNS, there is a dramatic increase in the 
amount of dee7-GAL4 activity as shown by GFP expression; maxillary palp injury, 
affecting a smaller number of ORNs, leads to a corresponding smaller amount dee7-
GAL4 expression (Doherty et al., submitted).  How do the glial cells sense the difference 
between the two injuries?  The integration of signaling pathways at the site of 
transcription is one possibility.     
Recent work by Johnna Doherty has shown that the Drosophila Signal Transducer 
and Activator of Transcription protein, STAT92E, is responsible for regulating both basal 
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and injury induced draper expression.  Upon sequence analysis, the dee7-GAL4 element 
described above contains three STAT92E consensus binding sites (Doherty et al, 
submitted).  It was determined that activation of this element by STAT92E was critical 
for maximal activation after axotomy; when one site was mutated and STAT92E could 
no longer bind and activate the fragment, GFP expression was decreased by about 50% 
when compared with controls.  Notably, the GFP expression was not completely absent.  
There are multiple possible explanations for this.  First, STAT92E may bind to multiple 
sites in order to activate draper expression and removing just one site may lessen but not 
abolish the activation.  Ongoing experiments are addressing this possibility with a dee7-
GAL4 fragment that has all three STAT sites mutated.  A second possibility is that STAT 
may require the binding of a co-factor or to be a part of complex in order to fully activate 
draper expression.  AP-1 has been shown to act in a complex with STAT to modulate 
immune signaling (Kim et al., 2007).  It has also been shown in vitro that AP-1 binding 
facilitates STAT binding to promote cytokine-induced immune responses in microglia 
and macrophages (Qin et al., 2007).   The STAT and AP-1 sites are in close proximity – 
the third STAT site is flanked by AP-1 binding sites which are 85 base pairs away on 
either side.  Because both sites are present within the injury-responsive element, it 
remains an interesting possibility that STAT and AP-1 are acting synergistically at the 
site of transcription factor binding to increase draper transcription.   
Interestingly, JNK has also been shown to be required for STAT activation.  In 
vitro, it has been shown that JNK can phosphorylate STAT to activate its transcriptional 
activity (Turkson et al., 1999; Liu et al., 2006; Miyazaki et al., 2008).  In addition to its 
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role in phosophorylating and activating AP-1 components, JNK may be phosphorylating 
and activating STAT in reactive glial cells, thereby enhancing the transcription of draper.  
To test this, we could utilize the 10XStat92E-dGFP reporter which has been shown to 
reflect STAT92E transcriptional activity both during development and in the adult 
(Doherty et al., submitted).  One day after injury, flies expressing this reporter show an 
increase in GFP expression surrounding the antennal lobes and throughout the brain 
(Doherty et al, submitted).  If JNK is required for full activation of STAT transcriptional 
activity, we would expect to see less GFP expression one day after injury when compared 
with control animals.     
Integration between STAT and JNK signaling may provide glial cells with a 
mechanism to determine the strength of response required.  In the case of the smaller 
injury invoked by maxillary palp ablation, Draper signaling may be moderately activated, 
leading to an activation of JNK and STAT that promotes weak activation of draper 
transcription.  It is possible in this situation that JNK selectively activates its downstream 
targets so that the phagocytosis of axonal debris occurs but signaling is not amplified; 
STAT would not be phosphorylated in this situation.  Alternatively, all downstream 
targets may be activated but to a lesser extent than after antennal injury.  In the case of a 
severe injury caused by antennal ablation, JNK and STAT may be strongly activated.  
JNK may then activate STAT in addition to activating its other targets, thereby 
amplifying the glial response to axonal injury.   
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Why is basal Draper not enough?   
It has been shown that even very low levels of basal (pre-injury) Draper are sufficient for 
glial cells to receive an injury signal.  Glial dJNK knockdown animals have normal levels 
of Draper before injury; these cells are able to respond to maxillary palp ablation by 
recruiting Draper to the maxillary nerve (Figure 2.4B).  Knocking down the PI3K/Akt 
signaling pathway, in contrast, results in significantly decreased levels of basal Draper 
but these animals show a dramatic increase of Draper levels after antennal ablation, 
indicating that the basal Draper that is present is sufficient for the glial cells to sense 
neuronal injury (Doherty, 2011).  These data tell us that even small amounts of Draper 
are sufficient for glia to activate potent responses to an axonal injury signal. 
 Work from the C. elegans field has recently shown that CED-1, the ortholog of 
Draper, plays a role in phagosome maturation and degradation of debris as well as in its 
initial engulfment (Yu et al., 2008).  This novel function appears to regulate the 
recruitment and function of RAB-7 through an unidentified mechanism involving DYN-
1, an ortholog of dynamin, and CED-6.  Rab GTPases are involved in many vesicle 
trafficking events; Rab7 has specifically been implicated in endocytosis and phagosomal 
maturation (Vieira et al., 2002).   
This study provides evidence that CED-1 may be involved in both recognition and 
engulfment of debris as well as its subsequent phagocytosis.  This may provide us with a 
model to explain the requirements for draper transcription in glial phagocytosis of 
degenerating axon debris.  It is possible that basal Draper/dCed-1 is required for the 
recognition of axonal debris; this activates downstream signaling pathways that activate 
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the glial cell and promote engulfment through mechanisms that include draper 
transcription.  However, this basal amount of Draper may not be sufficient to promote 
membrane extension, engulfment, and phagocytosis; a transcriptional increase in draper, 
downstream of Draper signaling, is required for these steps to occur and for axonal debris 
to be cleared from the CNS.  My data shows that the over-expression of Draper can 
rescue the clearance defects in dJNK knockdown animals.  Perhaps this transgene-
supplied excess of Draper provides the cell with enough of the protein to efficiently 
engulf and phagocytose of axonal debris and the requirement for a dJNK-governed 
transcriptional increase is overridden.   
It is also possible that the newly transcribed Draper is somehow different from 
basal Draper.  This variation could occur through post-transcriptional modifications, for 
example.  While it is known that the intracellular domain of Draper I is critical for 
engulfment and phagocytosis (Logan et al., 2012), a thorough structural analysis of basal 
Draper and injury-induced Draper has not been conducted, to my knowledge; this might 
lead to interesting insights into the various roles played by this molecule before and after 
Draper receptor activation.     
 
Non-transcriptional responses downstream of Rac and dJNK in glial cells after 
axonal injury 
 
In addition to the transcriptional activation of draper and other injury responsive genes, it 
is likely that there are other effects of Rac1 and dJNK activation that directly allow the 
glial cell to respond to and engulf the axonal debris.  The role of Rac1 in processes such 
as cell migration, chemotaxis, cytoskeletal rearrangement and phagocytosis is well 
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established (Reddien and Horvitz, 2000; Sun et al., 2004; Sepp, 2003).  In developing 
Drosophila embryos, Rac has been shown to mediate peripheral glial migration via 
effects on actin fibers (Sepp, 2003).  The movement of glia in response to axon injury 
may be similarly regulated by Rac; it is likely that Rac1 is exerting its effects on actin 
while also activating downstream signaling pathways such as JNK.   
 While best known for its effects on transcription, other non-transcriptional targets 
of JNK activation, such as neurofilament and microtubules, have been reported (Waetzig 
and Herdegen, 2003).  Evidence for JNK’s effects on microtubules has come from 
several studies.  In a culture of Cerebellar Granule Neurons, a large pool of activated 
JNK appears to be cytoplasmic; this localization would not allow transcriptional 
activation to be the primary downstream target of this pool of enzyme (Coffey et al., 
2000).  Activated JNK has also been found to co-localize with tubulin in the cytoplasm of 
cultured embryonic mouse neurons (Kawauchi et al., 2003).   The knockdown of JNK has 
been shown to lead to a loss of  microtubule integrity and dynamics, both of which lead 
to alterations in morphology or neurodegeneration (Chang et al., 2003b; Kawauchi et al., 
2003).  These studies suggest potential candidates for non-transcriptional targets of 
activated JNK that may be activated in glial cells in response to axonal injury; the 
identification of others could provide insight into the diversity of JNK’s effects within the 
cell.    
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The effect of glial dJNK knockdown on the termination of the glial response to 
axotomy 
 
The glial response to axotomy can be divided into three phases:  activation, engulfment, 
and termination.  In the termination phase, glial cells return to their “resting” state as 
Draper levels return to normal and glial membranes appear to return to their original 
locations.  Recently it was shown that this termination step requires the function of 
Draper II, an isoform of the Draper engulfment receptor formed through alternative 
splicing (Logan et al., 2012).  The intracellular portion of Draper II contains an inhibitory 
domain that drives the termination of the glial response to axotomy (Logan et al., 2012).  
Interestingly, Draper II (like Draper I) is transcriptionally activated after axotomy.  While 
the relative mRNA expression of Draper I is evident by 1.5 hours after injury and peaks 
around 3 hours after injury, the transcription of Draper II peaks around 4.5 hours after 
injury (Logan et al., 2012).   Draper II activity is critical for the “repriming” of glial cells.  
When Draper II is absent, clearance of injured axons occurs normally.  However, when a 
subsequent axotomy is performed in these animals, glia are not able to clear the debris 
from the CNS (Logan et al., 2012).  Draper II function appears critical for the “resetting” 
of glia after an initial response to axonal injury.       
Interestingly, when I knock down dJNK in glial cells, I see a persistence of glial 
activation.  When I look at the maxillary nerve, I can see Draper staining for at least 15 
days after injury; in control animals, this staining is not visible after 5 days post-injury.  
Recent work has demonstrated that the presence of axonal debris does not cause glial 
cells to remain in an activated state (Ziegenfuss et al., 2012).  For example when the 
Crk/MBC/dCed-12 complex is knocked down, glial cells respond to the site of injury, fail 
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to clear the debris, and return to their resting positions.  I hypothesize that dJNK is acting 
to regulate Draper II transcription.  Draper II is likely regulated by the same enhancer 
region as Draper I, which contains AP-1 binding sites as described previously.  When 
dJNK is knocked down, Draper II is not transcriptionally activated and therefore the 
engulfment response is not terminated.  To test this, we can perform qRT-PCR for Draper 
II in dJNK knock down animals to see if an increase in relative mRNA levels is detected.  
The effect of dJNK on the termination of the glial response has many potential 
implications.  As discussed briefly in the introduction, hyperactive glial cells have been 
implicated in human pathological conditions such as multiple sclerosis and chronic 
neuropathic pain.  Understanding how glial cells are “turned off” by dJNK and other 
transcriptional regulators would be an exciting path for future study.   
 
Future directions for studying the role of dJNK in glial engulfment and 
phagocytosis 
 
Visualizing AP-1 activity in vivo 
Until very recently, we have been unable to visually monitor AP-1 activity in vivo after 
axotomy.  However, the recent development of a transgenic fluorescent transcriptional 
reporter has provided a means of doing this (Chatterjee and Bohmann, 2012).  These 
constructs were designed by utilizing the known AP-1 preferred binding site sequences.  
Four copies of this so called TRE element were placed upstream of a basal promoter and 
a fluorescent protein; this construct was integrated into a specific genomic locus so that 
positional effects would be avoided (Chatterjee and Bohmann, 2012).  The constructs 
have been shown to accurately represent known patterns of JNK   
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Figure 3.4 
An AP-1 fluorescent reporter is increased in glia after axon injury 
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Figure 3.4 An AP-1 fluorescent reporter is increased in glia after axon injury 
 
 
An AP-1 transcriptional reporter has recently been created by cloning four AP-1 binding 
sites (“TRE elements”) in front of a fluorescent protein.  Using flies homozygous for this 
reporter, I surgically removed both antennae and maxillary palps to induce a large injury 
in the CNS.  Flies were kept at 25oC for one day before brains were fixed and dissected 
using a standard protocol (MacDonald et al., 2006).  Brains were stained with α-Repo 
antibody (1:5) to label glial nuclei.  Brains were mounted in Vectashield and imaged on a 
Zeiss LSM5 Pascal confocal microscope.  One day after injury there is a dramatic 
increase in GFP in the injured brains when compared with the uninjured brains.  GFP is 
seen surrounding the antennal lobe (arrows).  There also appears to be an increase in 
Repo/GFP co-labeled nuclei (which appear yellow, arrowheads).   
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signaling (Chatterjee and Bohmann, 2012).  To test whether AP-1 is activated after nerve 
injury in the Drosophila CNS, I performed antennal and maxillary palp ablations on flies 
expressing this transgene.  Preliminary experiments indicate that there is an increase in 
GFP expression one day after axotomy and that this increase is co-localized to glial cells 
(Figure 3.4).  This reinforces our model that dJNK signaling is activated and inducing 
transcriptional changes in reactive glial cells in response to axotomy.   
 This newly described AP-1 reporter will allow in-depth analysis of dJNK 
signaling in glial cells in response to nerve injury.  For example, we have yet to directly 
link Draper receptor activation with dJNK and AP-1 activity.  By using this reporter in a 
draper null background, we can determine if the Draper receptor acts upstream of AP-1 
activation.  The reporter can also be used to determine the role of other known 
engulfment genes (such as Rac, and Crk/MBC/dCed-12) in activating AP-1 activity. The 
exact role for dCed-6 has not been elucidated; by utilizing this reporter and performing 
axotomy, we can assess AP-1 activity to determine if dCed-6 acts upstream.  Utilization 
of this new tool will provide insight to the signaling that occurs in glia after axotomy.   
 
DTRAF1 as a possible link between the Draper receptor and dJNK signaling  
One major question that remains unanswered is how the Draper receptor activates 
downstream effectors.  We know that SRC42A and Shark are involved, but the molecular 
details of downstream target activation are unknown.  To begin answering this question I 
chose several candidates molecules that were known to activate JNK downstream of  
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Figure 3.5 
DTRAF1 is involved in Draper signaling in glial cells after axotomy 
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Figure 3.5 DTRAF1 is involved in Draper signaling in glial cells after axotomy 
 
 
To test if DTRAF1 is required in glial cells for the clearance of degenerating axons I 
expressed UAS-DTRAF1-IR (IR = inverted repeats) in all glial cells of flies expressing 
OR85e-mCD8::GFP using repo-GAL4.  Flies were raised at 25oC and aged for at least 7 
days after eclosion.  Maxillary palps were ablated and flies were kept at 25oC for 5 days.  
Brains were fixed and dissected using a standard protocol (MacDonald et al., 2006).  
Brains were stained with α-GFP antibody overnight at 4oC and with FITC anti-mouse 
IgG at room temperature for 3 hours.  Brains were mounted in Vectashield and imaged on 
a Zeiss LSM5 Pascal confocal microscope.  (A) shows a control brain 5 days after 
maxillary palp ablation with very little GFP+ axonal debris remaining.  The right panel 
shows a brain with DTRAF1 knocked down in glial cells.  There is a significant amount 
of GFP+ axonal material remaining; this is quantified in (B).   
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various receptors and knocked them down in glia using UAS-RNAi constructs.  One 
molecule, DTRAF1, gave an engulfment phenotype; a significant amount of GFP+  
axonal debris remained 5 days after axotomy when DTRAF1 was knocked down in glia 
by RNAi (Figure 3.5A-B) 
Tumor necrosis factor receptor-associated factors (TRAFs) are adaptor proteins 
that are typically signal transducing molecules that interact with receptors of the TNF or 
interleukin-1 receptor/Toll families (Muzio et al., 1998; Cao et al., 1996).  In mammals 
the activation of the six known members of the TRAF family and the resultant 
downstream signaling appears to be context dependent, but JNK activation is one known 
result (Min and Pober, 1997b; Song et al., 1997b; Kim et al., 1999).  In one culture 
system, the activation of JNK by TRAF involves Rac, although the exact mechanism is 
not reported (Min and Pober, 1997b).  In Drosophila, two TRAFs that are alternate splice 
forms of the same genetic locus have been identified (Liu et al., 1999; Zapata et al., 2000; 
Preiss et al., 2001).  DTRAF2 has only 19% identity to mammalian TRAFS (Preiss et al., 
2001).  It, like TRAF6, interacts with Pelle and ECSIT (evolutionarily conserved 
signaling intermediate in Toll pathways) to activate NF-KB signaling (Kopp et al., 1999; 
Cha et al., 2003).  DTRAF1 is most similar to TRAF4 (45% identical).  It was shown 
bind to MSN, a JNKKKK, in a yeast two-hybrid screen; this binding to MSN was shown 
to be critical for TRAF1 to activate JNK in vitro (Liu et al., 1999).  Later experiments in 
vivo also indicated that DTRAF1 acts upstream of JNK activation.  Could it be 
interacting with the Draper receptor to activate dJNK in glial cells?  This preliminary 
finding that knocking down DTRAF1 in glial cells with RNAi leads to a defect in the 
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clearance of degenerating axonal debris should be followed up to potentially uncover an 
exciting new role for DTRAF1 and a new component of the Draper signaling pathway.   
 
Conclusions 
The work performed in this thesis provides insight to the molecular processes underlying 
the engulfment and phagocytosis of degenerating axon debris by glial cells in Drosophila 
melanogaster.  My work uncovers a new in vivo role for the well known dJNK signaling 
cascade; the MAPKKKs Slipper and TAK1, the MAPKK MKK4, the MAPK dJNK and 
the transcription factor dAP-1 are each required for phagocytosis to occur.   
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